
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>IGFBP&#8208;3 and TGF&#8208;&#946; inhibit growth in epithelial cells by stimulating type V TGF&#8208;&#946; receptor (T&#946;R&#8208;V)&#8208;mediated tumor suppressor signaling - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC50000278DDB29AACC.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="fasebbioadv" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC8409558/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409558/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="FASEB BioAdvances" /><meta name="citation_title" content="IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating type V TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;V)&#x02010;mediated tumor suppressor signaling" /><meta name="citation_author" content="Chun&#x02010;Lin Chen" /><meta name="citation_author_institution" content="Department of Biological Science, National Sun Yat&#x02010;sen University, Kaohsiung Taiwan" /><meta name="citation_author_institution" content="Departments of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis MO, USA" /><meta name="citation_author" content="Franklin W. Huang" /><meta name="citation_author_institution" content="Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco CA, USA" /><meta name="citation_author" content="Shuan Shian Huang" /><meta name="citation_author_institution" content="Auxagen Inc., St. Louis MO, USA" /><meta name="citation_author" content="Jung San Huang" /><meta name="citation_author_institution" content="Departments of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis MO, USA" /><meta name="citation_publication_date" content="2021/09" /><meta name="citation_issue" content="9" /><meta name="citation_volume" content="3" /><meta name="citation_firstpage" content="709" /><meta name="citation_doi" content="10.1096/fba.2021-00016" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8409558/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8409558/" /><meta name="citation_pmid" content="34485840" /><meta name="DC.Title" content="IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating type V TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;V)&#x02010;mediated tumor suppressor signaling" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Wiley" /><meta name="DC.Contributor" content="Chun&#x02010;Lin Chen" /><meta name="DC.Contributor" content="Franklin W. Huang" /><meta name="DC.Contributor" content="Shuan Shian Huang" /><meta name="DC.Contributor" content="Jung San Huang" /><meta name="DC.Date" content="2021 Sep" /><meta name="DC.Identifier" content="10.1096/fba.2021-00016" /><meta name="DC.Language" content="en" /><meta property="og:title" content="IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating type V TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;V)&#x02010;mediated tumor suppressor signaling" /><meta property="og:type" content="article" /><meta property="og:description" content="The TGF&#x02010;&#x003b2; type V receptor (T&#x003b2;R&#x02010;V) mediates growth inhibition by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; in epithelial cells and loss of T&#x003b2;R&#x02010;V expression in these cells leads to development of carcinoma. ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409558/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8409558/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3792/">FASEB Bioadv</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/389192/">v.3(9); 2021 Sep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8409558
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8409558/pdf/FBA2-3-709.pdf" class="int-view">PDF (1.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8409558/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8409558/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8409558" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="PIGYYpvP2xOJu0Lw28iy4SDcgICHINMKXdr3MbSXjkazlrqn9pDwylfmB1KhTH5x">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F&amp;text=IGFBP%020103%20and%20TGF%02010%003B2%20inhibit%20growth%20in%20epithelial%20cells%20by%20stimulating%20type%20V%20TGF%02010%003B2%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409558/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34485840/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34485840/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8409558/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/3792/">FASEB Bioadv</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/389192/">v.3(9); 2021 Sep</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8409558
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-fasebbioadv.png" alt="Logo of fasebbioadv" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="https://onlinelibrary.wiley.com/journal/25739832" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">FASEB Bioadv.</span> 2021 Sep; 3(9): 709–729. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2021 Jun 16. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1096%2Ffba.2021-00016" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1096/fba.2021-00016</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8409558</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34485840">34485840</a></div></div></div><h1 class="content-title">IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating type V TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;V)&#x02010;mediated tumor suppressor signaling</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20C%5BAuthor%5D" id="fba21236-cr-0001" class="affpopup" co-rid="_co_idm140140770647296" co-class="co-affbox">Chun&#x02010;Lin Chen</a>,<sup>
1
,</sup><sup>
4
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20FW%5BAuthor%5D" id="fba21236-cr-0002" class="affpopup" co-rid="_co_idm140140770643568" co-class="co-affbox">Franklin W. Huang</a>,<sup>
2
</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20SS%5BAuthor%5D" id="fba21236-cr-0003" class="affpopup" co-rid="_co_idm140140810515856" co-class="co-affbox">Shuan Shian Huang</a>,<sup>
3
</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20JS%5BAuthor%5D" id="fba21236-cr-0004" class="affpopup" co-rid="_co_idm140140810513248" co-class="co-affbox">Jung San Huang</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>
4
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140140770647296"><h3 class="no_margin">Chun&#x02010;Lin Chen</h3><p>
<sup>
1
</sup>
Department of Biological Science, 
National Sun Yat&#x02010;sen University, 
Kaohsiung
Taiwan
</p><p>
<sup>
4
</sup>
Departments of Biochemistry and Molecular Biology, 
Saint Louis University School of Medicine, 
St. Louis
MO, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chen%20C%5BAuthor%5D">Chun&#x02010;Lin Chen</a></div></div><div id="_co_idm140140770643568"><h3 class="no_margin">Franklin W. Huang</h3><p>
<sup>
2
</sup>
Division of Hematology and Oncology, 
Department of Medicine, 
University of California, 
San Francisco
CA, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20FW%5BAuthor%5D">Franklin W. Huang</a></div></div><div id="_co_idm140140810515856"><h3 class="no_margin">Shuan Shian Huang</h3><p>
<sup>
3
</sup>
Auxagen Inc., 
St. Louis
MO, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20SS%5BAuthor%5D">Shuan Shian Huang</a></div></div><div id="_co_idm140140810513248"><h3 class="no_margin">Jung San Huang</h3><p>
<sup>
4
</sup>
Departments of Biochemistry and Molecular Biology, 
Saint Louis University School of Medicine, 
St. Louis
MO, 
USA
</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20JS%5BAuthor%5D">Jung San Huang</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140140812618304_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140140812618304_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140140812618304_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140140812618304_ai" style="display:none"><div class="fm-affl" id="fba21236-aff-0001">
<sup>
1
</sup>
Department of Biological Science, 
National Sun Yat&#x02010;sen University, 
Kaohsiung
Taiwan
</div><div class="fm-affl" id="fba21236-aff-0002">
<sup>
2
</sup>
Division of Hematology and Oncology, 
Department of Medicine, 
University of California, 
San Francisco
CA, 
USA
</div><div class="fm-affl" id="fba21236-aff-0003">
<sup>
3
</sup>
Auxagen Inc., 
St. Louis
MO, 
USA
</div><div class="fm-affl" id="fba21236-aff-0004">
<sup>
4
</sup>
Departments of Biochemistry and Molecular Biology, 
Saint Louis University School of Medicine, 
St. Louis
MO, 
USA
</div><div><span class="fm-affl">Jung San Huang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.uls@sjgnauh" class="oemail">ude.uls@sjgnauh</a></span>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div id="correspondenceTo"><sup>*</sup><strong>Correspondence</strong><br />
Jung S. Huang, Ph.D., Professor, Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, Doisy Research Center, Room 317, 1100 S. Grand Blvd., St. Louis, MO 63104, USA.<br />
Email: <a href="mailto:dev@null" data-email="ude.uls@sjgnauh" class="oemail">ude.uls@sjgnauh</a>
<br />
</div></div><div class="fm-article-notes hide half_rhythm" id="idm140140812618304_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2021 Feb 8; Revised 2021 Apr 6; Accepted 2021 Apr 23.</div></div><div class="permissions half_rhythm hide" id="idm140140812618304_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2021 The Authors. <em>FASEB BioAdvances</em> published by the Federation of American Societies for Experimental Biology</div><div class="license half_rhythm">This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="fba21236-abs-0001" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-abs-0001title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The TGF&#x02010;&#x003b2; type V receptor (T&#x003b2;R&#x02010;V) mediates growth inhibition by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; in epithelial cells and loss of T&#x003b2;R&#x02010;V expression in these cells leads to development of carcinoma. The mechanisms by which T&#x003b2;R&#x02010;V mediates growth inhibition (tumor suppressor) signaling remain elusive. Previous studies revealed that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;1/2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated protein phosphatase (PPase), resulting in dephosphorylation of pRb&#x02010;related proteins (p107, p130) or pRb, and growth arrest. To define the signaling, we characterized/identified the IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases in cell lysates and nucleus fractions in Mv1Lu cells treated with IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;, using a cell&#x02010;free assay with <sup>32</sup>P&#x02010;labeled casein as a substrate. Both IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities in cell lysates are abolished when cells are co&#x02010;treated with TGF&#x02010;&#x003b2;/IGFBP&#x02010;3 antagonist or RAP (LRP&#x02010;1/T&#x003b2;R&#x02010;V antagonist). However, the IGFBP&#x02010;3&#x02010;stimulated PPase activity, but not TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity, is sensitive to inhibition by okadaic acid (OA). In addition, OA or PP2A<sub>c</sub> siRNA reverses IGFBP&#x02010;3 growth inhibition, but not TGF&#x02010;&#x003b2; growth inhibition, in Mv1Lu and 32D cells. These suggest that IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases are identical to PP2A and PP1, respectively. By Western blot/phosphorimager/immunofluorescence&#x02010;microscopy analyses, IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<sub>c</sub> and PP1<sub>c</sub>, resulting in dephosphorylation of p130/p107 and pRb, respectively, and growth arrest. Small molecule TGF&#x02010;&#x003b2; enhancers, which potentiate TGF&#x02010;&#x003b2; growth inhibition by enhancing T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical signaling and thus activating T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb), could be used to prevent and treat carcinoma.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">IGFBP&#x02010;3, IRS&#x02010;1/2, PP1<sub>c</sub>
, PP2A<sub>c</sub>
, TGF&#x02010;&#x003b2;, T&#x003b2;R&#x02010;V</span></div></div><div id="fba21236-body-0001" class="tsec sec"><h2 class="headless nomenu"></h2><div class="def-list" id="fba21236-lp-0001"><h4>Abbreviations</h4><dl class="labeled-list"><dt>A549 cells</dt><dd>human Caucasian lung carcinoma cells</dd><dt>CDK</dt><dd>cyclin&#x02010;dependent kinase</dd><dt>CHO cells</dt><dd>Chinese hamster ovary epithelial cells</dd><dt>D32 cells</dt><dd>murine 32D myeloid cells</dd><dt>EMT</dt><dd>epithelial mesenchymal transition</dd><dt>IGF&#x02010;1</dt><dd>insulin&#x02010;like growth factor&#x02010;1</dd><dt>IGF&#x02010;2</dt><dd>insulin&#x02010;like growth factor&#x02010;1</dd><dt>IGFBP&#x02010;3</dt><dd>insulin&#x02010;like growth factor&#x02010;binding protein&#x02010;3</dd><dt>IR</dt><dd>insulin receptor</dd><dt>IRS&#x02010;1/2</dt><dd>insulin receptor substrate&#x02010;1/2</dd><dt>LRP&#x02010;1</dt><dd>low density lipoprotein receptor&#x02010;related protein&#x02010;1</dd><dt>Mv1Lu cells</dt><dd>mink lung epithelial cells</dd><dt>OA</dt><dd>okadaic acid</dd><dt>p107</dt><dd>p130, pRb&#x02010;related proteins</dd><dt>PAI&#x02010;1</dt><dd>plasminogen activator inhibitor&#x02010;1</dd><dt>PP1</dt><dd>protein phosphatase 1</dd><dt>PP1<sub>c</sub>
</dt><dd>36&#x02010;kDa PP1 catalytic subunit</dd><dt>PP2A</dt><dd>protein phosphatase 2A</dd><dt>PP2A&#x02010;B56</dt><dd>a 56&#x02010;kDa substrate&#x02010;recognition B subunit of PP2A</dd><dt>PP2A<sub>c</sub>
</dt><dd>37&#x02010;kDa PP2A catalytic subunit</dd><dt>PPase</dt><dd>protein phosphatase</dd><dt>pRb</dt><dd>retinoblastoma protein (p105)</dd><dt>RAP</dt><dd>receptor&#x02010;associated protein</dd><dt>siRNA</dt><dd>small interfering RNA</dd><dt>TGF&#x02010;&#x003b2;</dt><dd>transforming growth factor&#x02010;&#x003b2;</dd><dt>T&#x003b2;R&#x02010;I</dt><dd>type I TGF&#x02010;&#x003b2; receptor</dd><dt>T&#x003b2;R&#x02010;II</dt><dd>type II TGF&#x02010;&#x003b2; receptor</dd><dt>T&#x003b2;R&#x02010;III</dt><dd>type III TGF&#x02010;&#x003b2; receptor</dd><dt>T&#x003b2;R&#x02010;V</dt><dd>type V TGF&#x02010;&#x003b2; receptor</dd><dt>&#x003b2;<sub>1</sub>
<sup>25</sup>
</dt><dd>TGF&#x02010;&#x003b2; peptide antagonist containing amino acid residues 41<sup>st</sup> to 65<sup>th</sup> of human TGF&#x02010;&#x003b2;<sub>1</sub>
</dd></dl></div></div><div id="fba21236-sec-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0001title">1. INTRODUCTION</h2><p class="p p-first">Insulin&#x02010;like growth factor&#x02010;binding protein&#x02010;3 (IGFBP&#x02010;3) is a growth regulator which exhibits IGF&#x02010;dependent and &#x02010;independent growth inhibitory activities in target cells.<sup><a href="#fba21236-bib-0001" rid="fba21236-bib-0001" class=" bibr popnode">1</a></sup> In the IGF&#x02010;dependent activity, IGFBP&#x02010;3 inhibits cell growth by binding IGF&#x02010;1 and IGF&#x02010;2 and preventing them from binding to their receptor, the IGF&#x02010;1 receptor (IGF&#x02010;1R), in these cells. IGFBP&#x02010;3 is also capable of inhibiting growth of cells by directly interacting with its own specific receptor in cells. This specific IGFBP&#x02010;3 receptor in responsive cells has been identified as the type V TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;V) which was discovered in our lab in 1991.<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0006" rid="fba21236-bib-0006" class=" bibr popnode">6</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> It is identical to low density lipoprotein receptor&#x02010;related protein 1 (LRP&#x02010;1).<sup><a href="#fba21236-bib-0008" rid="fba21236-bib-0008" class=" bibr popnode">8</a></sup> IGFBP&#x02010;3 inhibits the growth of wild&#x02010;type mink lung epithelial cells (Mv1Lu cells), which express type I, type II, type III, and type V TGF&#x02010;&#x003b2; receptors (T&#x003b2;R&#x02010;I, T&#x003b2;R&#x02010;II, T&#x003b2;R&#x02010;III, and T&#x003b2;R&#x02010;V), T&#x003b2;R&#x02010;I&#x02010;deficient Mv1Lu cells (R1B cells), and T&#x003b2;R&#x02010;II&#x02010;deficient Mv1Lu cells (DR26 cells).<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> Mv1Lu cells have been a model normal epithelial cell system to study TGF&#x02010;&#x003b2; activity and signaling.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> All of these wild&#x02010;type and mutant cells express T&#x003b2;R&#x02010;V. IGFBP&#x02010;3 does not bind to T&#x003b2;R&#x02010;I, T&#x003b2;R&#x02010;II, and T&#x003b2;R&#x02010;III in these cells.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup> The half maximal concentration of IGFBP&#x02010;3 for inhibiting growth of these cells is close to its K<sub>d</sub> (0.3&#x000a0;&#x000b5;g/ml or 10&#x000a0;nM) for binding to T&#x003b2;R&#x02010;V,<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> suggesting that IGFBP&#x02010;3&#x02010;induced growth inhibition is mainly mediated by T&#x003b2;R&#x02010;V in target cells. IGFBP&#x02010;3 maximally inhibits growth in these wild&#x02010;type and mutant cells by ~30%&#x02013;60%.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup> The T&#x003b2;R&#x02010;V is absolutely required for growth inhibition by either IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; in target normal epithelial cells.<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0006" rid="fba21236-bib-0006" class=" bibr popnode">6</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; are non&#x02010;covalent and covalent homodimers, respectively, containing a minimal active site motif of WS/CXD.<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0011" rid="fba21236-bib-0011" class=" bibr popnode">11</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0012" rid="fba21236-bib-0012" class=" bibr popnode">12</a></sup> They bind to the cell surface subdomains of T&#x003b2;R&#x02010;V at distinct sites. IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; bind to cell surface subdomains II and IV, and a site between subdomains I and II of T&#x003b2;R&#x02010;V, respectively.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> TGF&#x02010;&#x003b2; at 50&#x000a0;pM mildly and moderately inhibits growth in cells expressing T&#x003b2;R&#x02010;V but lacking T&#x003b2;R&#x02010;I or T&#x003b2;R&#x02010;II such as R1B and DR26 cells by ~15 and ~30% growth inhibition, respectively.<sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> However, TGF&#x02010;&#x003b2; at 1&#x02013;5&#x000a0;pM potently inhibits growth (~100% inhibition) in wild&#x02010;type Mv1Lu cells by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated growth inhibition (tumor suppressor) signaling in concert with canonical TGF&#x02010;&#x003b2; signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4)<sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> in wild&#x02010;type Mv1Lu cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup> Canonical TGF&#x02010;&#x003b2; signaling potentiates T&#x003b2;R&#x02010;V&#x02010;mediated growth inhibition from 15 or 30% in mutant R1B and DR&#x02010;26 cells (at 50&#x000a0;pM TGF&#x02010;&#x003b2;) to ~100% TGF&#x02010;&#x003b2; (at 1&#x02013;5&#x000a0;pM) growth inhibition by transcriptional activation of cyclin&#x02010;dependent kinase (CDK) inhibitors in wild&#x02010;type Mv1Lu cells.<sup><a href="#fba21236-bib-0014" rid="fba21236-bib-0014" class=" bibr popnode">14</a></sup> These suggest that T&#x003b2;R&#x02010;V mediates mild or moderate TGF&#x02010;&#x003b2; growth inhibition in mutant Mv1Lu cells (R1B and DR26 cells) lacking T&#x003b2;R&#x02010;I or T&#x003b2;R&#x02010;II, whereas T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical signaling is required for potent TGF&#x02010;&#x003b2; growth inhibition mediated by T&#x003b2;R&#x02010;V in wild&#x02010;type Mv1Lu cells. Absence of TGF&#x02010;&#x003b2;&#x02010;stimulated canonical signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4) in R1B cells results in complete loss of TGF&#x02010;&#x003b2; (at &#x02264;5&#x000a0;pM) growth inhibition activity in these cells.<sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup>
</p><p>IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; do not inhibit growth in cells lacking T&#x003b2;R&#x02010;V, such as homozygous LRP&#x02010;1&#x02010;deficient mouse embryonic fibroblasts (PEA&#x02010;13 cells), CHO cells deficient in LRP&#x02010;1 (CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells) and H1299 human non&#x02010;small cell lung carcinoma cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> PEA&#x02010;13, H1299, and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells express both T&#x003b2;R&#x02010;I and T&#x003b2;R&#x02010;II, and respond to TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II&#x02010;mediated transcriptional activation of extracellular matrix (ECM)&#x02010;related genes, such as PAI&#x02010;1.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> Wild&#x02010;type mouse embryonic fibroblasts (MEF) are sensitive to growth inhibition by either TGF&#x02010;&#x003b2; or IGFBP&#x02010;3.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> H1299 and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells exhibit a spindle&#x02010;shaped fibroblastoid morphology, frequently observed in invasive carcinoma cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0015" rid="fba21236-bib-0015" class=" bibr popnode">15</a></sup> Stable transfection of H1299 and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells with T&#x003b2;R&#x02010;V/LRP&#x02010;1 cDNA confers sensitivity to either TGF&#x02010;&#x003b2; or IGFBP&#x02010;3 growth inhibition and restores normal squamous epithelial morphology.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0015" rid="fba21236-bib-0015" class=" bibr popnode">15</a></sup> These results suggest that T&#x003b2;R&#x02010;V is essential for IGF&#x02010;independent growth inhibition by IGFBP&#x02010;3 and potent growth inhibition by TGF&#x02010;&#x003b2; in epithelial cells. These results also support the notion that T&#x003b2;R&#x02010;V acts as a tumor suppressor gene which causes cancer when it is inactivated or turned off.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> This notion is also supported by the recent findings that primary tumors from a few hundred human patients with liver, colon and prostate cancers in China, France and Argentina, respectively, exhibit loss or very low levels of LRP&#x02010;1 (T&#x003b2;R&#x02010;V) expression.<sup><a href="#fba21236-bib-0016" rid="fba21236-bib-0016" class=" bibr popnode">16</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0017" rid="fba21236-bib-0017" class=" bibr popnode">17</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0018" rid="fba21236-bib-0018" class=" bibr popnode">18</a></sup> Understanding of the mechanisms whereby the T&#x003b2;R&#x02010;V mediates growth inhibition (tumor suppressor) signaling stimulated by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; should be important to elucidate the molecular basis of IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; actions and to understand their roles in human cancers.<sup><a href="#fba21236-bib-0019" rid="fba21236-bib-0019" class=" bibr popnode">19</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0020" rid="fba21236-bib-0020" class=" bibr popnode">20</a></sup> IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; are moderate and potent growth inhibitory cytokines for epithelial cells, respectively. IGFBP&#x02010;3 acts as a tumor suppressor gene in several human carcinoma cancers examined.<sup><a href="#fba21236-bib-0020" rid="fba21236-bib-0020" class=" bibr popnode">20</a></sup> TGF&#x02010;&#x003b2; acts as a tumor suppressor at the early stage of carcinogenesis and a tumor promoter in late&#x02010;stage cancer.<sup><a href="#fba21236-bib-0019" rid="fba21236-bib-0019" class=" bibr popnode">19</a></sup> As a tumor suppressor, TGF&#x02010;&#x003b2; suppresses carcinogenesis by potently inhibiting growth in epithelial cells for maintaining normal squamous epithelial morphology and physiology.<sup><a href="#fba21236-bib-0021" rid="fba21236-bib-0021" class=" bibr popnode">21</a></sup>
</p><p class="p p-last">We previously demonstrated that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling which involves IRS&#x02010;1/2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated protein phosphatase (PPase), and dephosphorylation of retinoblastoma family proteins in the nucleus, resulting in cell growth arrest.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> In this communication, we demonstrate the identification of IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases as PPase 2A (PP2A) and PPase 1 (PP1), which are the master regulators of the eukaryotic cell cycle, respectively, based on the distinct sensitivity of these PPase activities to okadeic acid (OA) and PP2A<sub>c</sub> siRNA. By [Methy&#x02010;<sup>3</sup>H] thymidine incorporation/Western blot/phosphorimager/immunofluorescence&#x02010;microscopy analyses, we also demonstrate that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate IRS&#x02010;2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<sub>c</sub> and PP1<sub>c</sub>, resulting in dephosphorylation of pRb&#x02010;related proteins (p130 or p107) and pRb (p105) in the nucleus, respectively, in epithelial cells and growth arrest.</p></div><div id="fba21236-sec-0002" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0002title">2. MATERIALS AND METHODS</h2><div id="fba21236-sec-0003" class="sec sec-first"><h3 id="fba21236-sec-0003title">2.1. Materials</h3><p class="p p-first-last">All chemicals used in the experiments were prepared as a 10&#x000a0;mM stock solution in DMSO. The final concentration of DMSO in all experiments was 0.1% or lower, which had no effect on IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; activity. Human receptor&#x02010;associated protein (RAP) was provided by Dr. Dudley K. Strickland (Department of Vascular Biology, American Red Cross). [&#x003b3;&#x02010;<sup>32</sup>P]ATP, [<sup>32</sup>P]&#x02010;orthophosphate and [methyl&#x02010;<sup>3</sup>H] thymidine (67&#x000a0;Ci/mmol) were purchased from ICN Biochemicals (Irvine, CA, USA). Okadaic acid (OA) was purchased from Tocris. IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;1 (TGF&#x02010;&#x003b2;) were purchased from Peprotech. Insulin (A11382II) was purchased from Gibco. Primary antibodies against IRS&#x02010;1 (sc&#x02010;398), IRS&#x02010;2 (sc&#x02010;390761), PP1<sub>c</sub> (37&#x02010;kDa catalytic subunit) (sc&#x02010;7482), pRb (p105) (sc&#x02010;65230), p107 (sc&#x02010;250), p130 (sc&#x02010;374521), phosphorylated Smad2 (P&#x02010;Smad2) (sc&#x02010;135644), Ser 270&#x02010;phosphorylated IRS&#x02010;1/2 (P&#x02010;IRS&#x02010;1/2) (sc&#x02010;17192), &#x003b2;&#x02010;actin (sc&#x02010;47778), and lamin B (sc&#x02010;6216) were purchased from Santa Cruz Biotechnology. Rabbit antibodies against N&#x02010; and C&#x02010;terminal of human LRP&#x02010;1 (T&#x003b2;R&#x02010;V) were purchased from Sigma Chemical Co. and Abcam, respectively. Rabbit polyclonal antibodies against hyperphosphoryrated Rb (P&#x02010;Rb) (#8516) and PP2A<sub>c</sub> (36&#x02010;kDa PP2A catalytic subunit) (#2038) were purchased from Cell Signaling Technology. Alexa Fluor 488&#x02010; and 594&#x02010;conjugated secondary antibodies were purchased from Thermo Fisher. Secondary antibodies conjugated with horseradish peroxidase (Millipore, USA) and enhanced chemiluminescence (ECL) kit (Perkin&#x02010;Elmer Life Sciences) were used to develop immunoblots. TGF&#x02010;&#x003b2; peptide antagonist [&#x003b2;<sub>1</sub>
<sup>25</sup>], a dual TGF&#x02010;&#x003b2;/IGFBP&#x02010;3 antagonist, was synthesized as previously described.<sup><a href="#fba21236-bib-0011" rid="fba21236-bib-0011" class=" bibr popnode">11</a></sup>
</p></div><div id="fba21236-sec-0004" class="sec"><h3 id="fba21236-sec-0004title">2.2. Cell culture</h3><p class="p p-first-last">Mv1Lu cells (CCL&#x02010;64) and human lung adenocarcinoma cell line A549 (CCL&#x02010;185) were purchased from ATCC. 32D cells (murine 32D myeloid cells stably expressing human insulin receptor (IR) and IRS&#x02010;2)<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> were provided by Dr. Martin G. Myers, Jr. (Joslin Diabetes Center, Harvard University). CHO&#x02010;K1 cells were purchased from American Type Culture Collection (Rockville, MD, USA). CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cell<sup><a href="#fba21236-bib-0024" rid="fba21236-bib-0024" class=" bibr popnode">24</a></sup> were provided by Dr. Guejun Bu, Department of Pediatrics and Cell Biology and Physiology, Washington University School of Medicine. CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells were generated from CHO&#x02010;K1 cells by ethyl methane sulfate mutagenesis followed by pseudomonas exotoxin (PE)&#x02010;mediated selection of LRP&#x02010;1&#x02010;deficient cells.<sup><a href="#fba21236-bib-0024" rid="fba21236-bib-0024" class=" bibr popnode">24</a></sup> 32D cells stably expressing IR and IRS&#x02010;2 were grown in RPMI 1640 medium containing 10% fetal bovine serum and 5% WEHI conditioned medium according to the procedure provided by Dr. Martin G. Myers. CHO Cells were grown in DMEM/Ham's F&#x02010;12 medium containing 10% fetal bovine serum. Other cell lines used in this study were maintained in DMEM containing 50&#x000a0;U/mL each of penicillin and streptomycin and 10% fetal bovine serum (Invitrogen) in humidified incubators at 37&#x000b0;C and 5% CO<sub>2</sub>.</p></div><div id="fba21236-sec-0005" class="sec"><h3 id="fba21236-sec-0005title">2.3. PPase activity assay</h3><p class="p p-first"><sup>32</sup>P&#x02010;labeled casein was prepared by incubation of casein (21.6&#x000a0;mg) in 50&#x000a0;mM Tris&#x02013;HCl, pH 7.0, containing 10% glycerol, 1&#x000a0;mM benzamidine, 0.1&#x000a0;mM PMSF, 14&#x000a0;mM mercaptoethanol, 0.2&#x000a0;mM [&#x003b3;&#x02010;<sup>32</sup>P] ATP (200&#x000a0;cpm/pmol), 10&#x000a0;mM MgCl<sub>2</sub>, and 1.5&#x000a0;Unit/ml of the catalytic subunit of protein kinase A in a final volume of 3&#x000a0;ml. After overnight incubation at room temperature, the solution was filtered on a column (1.5&#x000a0;&#x000d7;&#x000a0;20&#x000a0;cm) of Sephadex 50G equilibriated in 50&#x000a0;mM Tris&#x02013;HCl containing 10% glycerol and 1&#x000a0;mM benzamidine. Before stimulation with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;, cells were treated with or without 25&#x000a0;&#x000b5;g/ml of RAP (receptor&#x02010;associated protein) and 30&#x000a0;&#x000b5;g/ml of TGF&#x02010;&#x003b2; peptide antagonist (&#x003b2;<sub>1</sub>
<sup>25</sup>) in serum&#x02010;free DMEM or DMEM/Ham's F&#x02010;12 medium for 10&#x000a0;min. The cells were stimulated with IGFBP&#x02010;3 (0.6&#x000a0;&#x000b5;g/ml) or TGF&#x02010;&#x003b2; (40&#x000a0;pM) for 3&#x000a0;hr. The cells were washed with cold phosphate&#x02010;buffered saline (PBS), detached with 50&#x000a0;mM Tris&#x02013;HCl pH 7.0 containing 0.25&#x000a0;M sucrose, 5&#x000a0;mM EDTA, and pelleted at 1,500&#x000a0;rpm for 5&#x000a0;min at 4&#x000b0;C. The cells were then lysed in 50&#x000a0;&#x000b5;l of homogenization buffer (50&#x000a0;mM Tris&#x02013;HCl, pH 7.0 containing 150&#x000a0;mM NaCl, 1% Triton X&#x02010;100, and 0.1&#x000a0;mM PMSF).</p><p>The PPase activity assay mixtures were composed of 50&#x000a0;mM Tris&#x02013;HCl, pH 7.0 containing 10% glycerol, 1&#x000a0;mM benzamidine, 0.1&#x000a0;mM PMSF, 14&#x000a0;mM mercaptoethanol, 0.1&#x000a0;mg of bovine serum albumin (BSA), PPase&#x02010;containing sample (cell lysates or nucleus extracts containing 5&#x000a0;&#x000b5;g protein), and <sup>32</sup>P&#x02010;labeled substrate in a final volume of 0.05&#x000a0;ml. Reactions in triplicates were initiated with the <sup>32</sup>P&#x02010;labeled casein at 30&#x000b0;C, and after a 10&#x000a0;min reaction period, 0.1&#x000a0;ml of 10% trichloroacetic acid (TCA) was added. The mixture was centrifuged at 12,000&#x000a0;g for 2&#x000a0;min in a microcentrifuge. About 0.1&#x000a0;ml of the supernatant was then added to 1&#x000a0;ml scintillation counting liquid, and radioactivity was determined.</p><p class="p p-last">The lysates from cells treated with vehicle only exhibited non&#x02010;specific PPase activity (IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;independent PPase activity with certain ~10<sup>2</sup>&#x02013;10<sup>3</sup>&#x000a0;cpm; 200&#x000a0;cpm/pmol phosphate). This non&#x02010;specific PPase activity was subtracted from the total PPase activity in the cell lysates from cells treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; in order to estimate IGFBP&#x02010;3&#x02010;stimulated or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity. For this reason, the mean (&#x000b1;SD) of the non&#x02010;specific PPase activity from triplicates was taken as 0&#x000a0;cpm in cells treated with vehicle only.</p></div><div id="fba21236-sec-0006" class="sec"><h3 id="fba21236-sec-0006title">2.4. Immunofluorescence microscopy</h3><p class="p p-first-last">One milliliter of culture media containing approximately 5,000&#x02013;10,000 Mv1Lu cells was added to a 35&#x000a0;mm culture dish containing a square coverslip. Mv1Lu cells grown on coverslips were treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;. Cells were then fixed in 4% paraformaldehyde for 15&#x000a0;min followed by permeabilization. Fixed cells were blocked with 5% BSA in PBS for 20&#x000a0;min at room temperature (RT) and then incubated with an appropriate primary antibody solution overnight at 4&#x000b0;C. Fixed cells were incubated with Alexa Fluor&#x02010;conjugated secondary antibodies for 1&#x000a0;hr at RT. Samples were observed with a Zeiss AxioObserver Z1 microscope (Zeiss), and images were captured using AxioVision Rev 4.6 software. To determine the nuclear localization and the colocalization of PP1<sub>c</sub> and hyperphosphorylated pRb (P&#x02010;Rb), the images were analyzed in three dimensions using an AxioObserver Z1 Apotome microscope (Zeiss). Colocalization was evaluated in single optical planes taken through the entire z&#x02010;axis of each cell. All images were acquired using identical intensity and photodetector gain to allow quantitative comparisons of relative levels of immunoreactivity between samples. All images were cropped and sized using ImageJ.</p></div><div id="fba21236-sec-0007" class="sec"><h3 id="fba21236-sec-0007title">2.5. Nucleus fractionation for PPase activity assay</h3><p class="p p-first-last">Nuclear extracts of the cells were prepared by hypotonic lysis followed by high salt extraction. Briefly, cell pellets were homogenized in 0.5&#x000a0;mL of ice&#x02010;cold lysis buffer, composed of 10&#x000a0;mM HEPES pH 7.9, 10&#x000a0;mM KCl, 2&#x000a0;mM MgCl<sub>2</sub>, 0.1&#x000a0;mM EDTA, 1&#x000a0;mM dithiothreitol (DTT), and 0.5&#x000a0;mM phenylmethylsulfonyl fluoride (all from Sigma Chemical Co.). The homogenates were centrifuged for 30&#x000a0;s at 500&#x000a0;g at 4&#x000b0;C to eliminate any unbroken tissue. The supernatants were incubated on ice for 20&#x000a0;min, vortexed for 30&#x000a0;s after the addition of 50&#x000a0;&#x003bc;L of 10% Nonidet P&#x02010;40 (Sigma Chemical Co.), and then centrifuged for 1&#x000a0;min at 5,000&#x000a0;g at 4&#x000b0;C. The crude nucleus pellet was suspended in 200&#x000a0;&#x003bc;L of ice&#x02010;cold extraction buffer (20&#x000a0;mM HEPES pH 7.9, 420&#x000a0;mM NaCl, 1.5&#x000a0;mM MgCl<sub>2</sub>, 0.1&#x000a0;mM EDTA, 1&#x000a0;mM DTT, and 0.5&#x000a0;mM PMSF) and incubated on ice for 30&#x000a0;min, mixed frequently, and centrifuged at 12,000&#x000a0;g at 4&#x000b0;C for 15&#x000a0;min. The supernatants were collected as nucleus extracts for Western blot and PPase activity assay. Protein concentration was determined using a bicinchoninic acid assay kit with BSA as the standard (Pierce Biochemicals).</p></div><div id="fba21236-sec-0008" class="sec"><h3 id="fba21236-sec-0008title">2.6. siRNA interference</h3><p class="p p-first-last">Murine PP2A<sub>c</sub> siRNA oligonucleotide corresponding to nucleotide sequence 5&#x02019;&#x02010;xxx&#x02010;3&#x02019; (ON&#x02010;TARGETplus SMARTpool Cat #: L&#x02010;040657&#x02013;00) and negative control siRNA were obtained from Dharmacon. PP2A<sub>c</sub> siRNA and negative control siRNA were resuspended in in RNase&#x02010;free water and stored at &#x02212;80&#x000b0;C. Transfection of siRNA was carried out using electroporation (Bio&#x02010;Rad Gene Pulser Xcell Total System). Three million cells in 600&#x000a0;&#x000b5;l of RPMI 1640 were incubated with siRNA in a 0.4&#x000a0;cm cuvette for 5&#x000a0;min on ice before electroporation (260&#x000a0;V, 950&#x000a0;&#x000b5;F). After additional 5&#x02010;min incubation on ice, cells were re&#x02010;suspended in 12&#x000a0;ml of RPMI 1640 supplemented with glutamine and 10% FCS (fetal calf serum) without antibiotic. Antibiotics (1% penicillin/streptomycin) were added at 6&#x000a0;hr after electroporation. All measurements were performed at 24 or 72 hr after transfection.</p></div><div id="fba21236-sec-0009" class="sec"><h3 id="fba21236-sec-0009title">2.7. [Methy&#x02010;<sup>3</sup>H] thymidine incorporation</h3><p class="p p-first-last">Growth of OA&#x02010;treated Mv1Lu cells and PP2A<sub>c</sub> siRNA knocked&#x02010;down 32D cells were determined by the measurement of [methy&#x02010;<sup>3</sup>H] thymidine incorporation into cellular DNA as described previously.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0012" rid="fba21236-bib-0012" class=" bibr popnode">12</a></sup> Briefly, cells grown to near confluence in 48&#x02010;well dishes were treated with several concentrations of OA at 37&#x000b0;C for 1&#x000a0;hr in serum&#x02010;free DMEM. The final concentration of DMSO was 0.2%. Treated cells were then incubated with 0.1 and 0.2&#x000a0;&#x000b5;g/ml IGFBP&#x02010;3, or 40&#x000a0;pM TGF&#x02010;&#x003b2; in DMEM containing 0.1% FCS at 37&#x000b0;C for 18&#x000a0;hr. The [methy&#x02010;<sup>3</sup>H] thymidine incorporation into cellular DNA was determined by incubation of cells with [methy&#x02010;<sup>3</sup>H] thymidine for 6&#x000a0;hr.</p></div><div id="fba21236-sec-0010" class="sec"><h3 id="fba21236-sec-0010title">2.8. Western blot</h3><p class="p p-first-last">Seventy&#x02010;two hours after siRNA transfection, 32D and Mv1Lu cells (3&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells) were lysed with 100&#x000a0;&#x000b5;l, 50&#x000a0;mM Tris&#x02013;HCl, pH 7.0 containing 1% Triton X&#x02010;100, 150&#x000a0;mM NaCl, 5&#x000a0;mM EDTA, and 0.1&#x000a0;mM PMSF. Cell lysates were subjected to 7.5% SDS&#x02010;PAGE and Western blotting using specific antibodies (Santa Cruz Biotechnology) as described previously.<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> The antigens on the blots were visualized using horseradish oxidase&#x02010;conjugated anti&#x02010;rabbit IgG antibody and ECL system.</p></div><div id="fba21236-sec-0011" class="sec"><h3 id="fba21236-sec-0011title">2.9. Metabolic labeling and immunoprecipitation</h3><p class="p p-first-last">Mv1Lu and 32D cells (3&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells) grown in 6&#x02010;well plate were washed and incubated in phosphate&#x02010;free DMEM for 1&#x000a0;hr to deplete intracellular phosphate. After 2&#x000a0;hr of incubation with [<sup>32</sup>P] orthophosphate at 37&#x000b0;C in a CO<sub>2</sub> incubator, cells were treated with 1&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 and/or OA (and RAP) for 16&#x000a0;hr. Cell lysates were prepared by suspending cells in 600&#x000a0;&#x000b5;l of lysis buffer and p130 or p107 was immunoprecipitated with a rabbit polyclonal antibody against the N&#x02010;terminal domain of p130 or p107. The p130 or p107 antibody complex was captured with a protein G&#x02010;coated agarose beads. The immunoprecipitated proteins were resolved using 7.5% SDS&#x02010;PAGE. The gel was dried and autoradiographed by a phosphorimager.</p></div><div id="fba21236-sec-0012" class="sec sec-last"><h3 id="fba21236-sec-0012title">2.10. Statistical analysis</h3><p class="p p-first-last">Two&#x02010;tailed unpaired Student's <em>t</em>&#x02010;test was used for determining the significance of a difference between two (vehicle only and sample) means. It was mainly used to compare the means between two groups (vehicle only and one specific concentration of IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;). The values were presented as mean&#x000a0;&#x000b1;&#x000a0;SD. <em>p</em>&#x000a0;&#x0003c;&#x000a0;0.05 was considered significant.</p></div></div><div id="fba21236-sec-0013" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0013title">3. RESULTS</h2><div id="fba21236-sec-0014" class="sec sec-first"><h3 id="fba21236-sec-0014title">3.1. IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities are distinct in the sensitivity to OA inhibition in Mv1Lu cells</h3><p class="p p-first">We previously proposed a model for the mechanisms by which IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; inhibit growth in epithelial cells by stimulating T&#x003b2;R&#x02010;V/IRS&#x02010;1/2/PPase signaling.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> However, in this model, the identity of IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase was unknown. To characterize and identify the IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases, we developed a cell&#x02010;free PPase activity assay. In this assay, <sup>32</sup>P&#x02010;phosphorylated casein, which was generated by <sup>32</sup>P&#x02010;phosphate&#x02010;labeling (<sup>32</sup>P&#x02010;labeling) of casein (dephosphorylated) with protein kinase A in the presence of &#x003b3;&#x02010;<sup>32</sup>P&#x02010;ATP, was incubated with cell lysates of Mv1Lu cells treated with or without IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;1 (TGF&#x02010;&#x003b2;). After incubation, <sup>32</sup>P&#x02010;phosphate released from <sup>32</sup>P&#x02010;casein via the action of stimulated PPase in cell lysates and nucleus extracts were separated from remaining <sup>32</sup>P&#x02010;casein by 10% trichloroacetic acid (TCA) precipitation in the presence of a carrier protein (BSA). The <sup>32</sup>P&#x02010;phosphate released was recovered in the supernate of the 10% TCA solution. The IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities were estimated by subtracting the radioactivity of <sup>32</sup>P&#x02010;phosphate released by cell lysates or nucleus extracts of cells treated without IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; from that released by cell lysates or nucleus extracts of cells treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;. Using this assay, we characterized the kinetics, IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; concentration dependence and OA sensitivity of the IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity in Mv1Lu cells. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1</span></a>, IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulated the PPase activities in a time&#x02010; and concentration&#x02010;dependent manner. The IGFBP&#x02010;3&#x02010;stimulated PPase activity in the cell lysates appeared to be linear with time up to 3&#x000a0;hr treatment in these cells treated with 1&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1A</span></a>). The TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity in the cell lysates also exhibited a linear relationship with the treatment time for 3&#x000a0;hr in Mv1Lu cells treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; (data not shown). IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulated the PPase activities in a concentration&#x02010;dependent manner (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1B</span></a> and Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1C</span></a>, respectively). The half&#x02010;maximum concentration of IGFBP&#x02010;3 to stimulate the PPase activity was estimated to be ~10&#x000a0;nM (0.3&#x000a0;&#x003bc;g/ml) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1B</span></a>) which is close to the half&#x02010;maximum concentration of IGFBP&#x02010;3 for binding to the IGFBP&#x02010;3 receptor (T&#x003b2;R&#x02010;V) and for inhibiting cell growth in Mv1Lu cells.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup> TGF&#x02010;&#x003b2; also stimulated a PPsse activity in Mv1Lu cells in a concentration&#x02010;dependent manner with a half&#x02010;maximum concentration of ~40&#x000a0;pM which is close to the K<sub>d</sub> (50&#x000a0;pM) of TGF&#x02010;&#x003b2; binding to T&#x003b2;R&#x02010;V<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup> in these cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1C</span></a>). TGF&#x02010;&#x003b2; at 10&#x000a0;pM stimulated a significant level of PPase activity (0.8&#x000a0;&#x000d7;&#x000a0;10<sup>3</sup>&#x000a0;cpm; 200&#x000a0;cpm/pmol phosphate) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1C</span></a>). However, the IGFBP&#x02010;3&#x02010;stimulated PPase activity is distinct from the TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity in its greater sensitivity to OA inhibition. OA at 0.5&#x000a0;nM completely inhibited the IGFBP&#x02010;3&#x02010;stimulated PPase activity (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1D</span></a>). OA at 1&#x000a0;nM did not significantly affect the TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1D</span></a>). These results suggest that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate PPase activities by interaction with T&#x003b2;R&#x02010;V in Mv1Lu cells and that IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases are different enzymes with distinct sensitivity to OA inhibition in these cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140769813680"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g003.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g003.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g003.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140769813680"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0001"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001">FIGURE 1</a></div><!--caption a7--><div class="caption"><p>IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate PPase activities in a time (A)&#x02010; and concentration (B, C)&#x02010;dependent manner but with distinct sensitivity to OA inhibition (D) in Mv1Lu cells. Cells were treated with vehicle only, 1&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 (A), different concentrations of IGFBP&#x02010;3 (B) and TGF&#x02010;&#x003b2; (C) or treated with 0.6&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 or 40&#x000a0;pM TGF&#x02010;&#x003b2; in the presence of several concentrations of OA (D). After different time periods (A) or 2&#x000a0;hr incubation (B,C,D), cell lysates were assayed using <sup>32</sup>P&#x02010;casein as substrate for assaying IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity. The IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity (200&#x000a0;cpm/pmole phosphate) was estimated by subtracting the <sup>32</sup>P radioactivity (cpm) released from <sup>32</sup>P&#x02010;casein by cell lysates of cells treated with vehicle only from that released by cell lysates of cells treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;. The assays were performed in triplicates. The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly higher (B,C) or lower (D) than that of cells treated with vehicle only (control) or with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; only: <em>p&#x000a0;</em>&#x0003c;&#x000a0;0.001</p></div></div></div></div><div id="fba21236-sec-0015" class="sec"><h3 id="fba21236-sec-0015title">3.2. IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate PPase activities in a T&#x003b2;R&#x02010;V&#x02010;dependent manner in Mv1Lu and CHO&#x02010;K1 cells</h3><p class="p p-first">The T&#x003b2;R&#x02010;V has been identified as the IGFBP&#x02010;3 receptor which mediates its IGF&#x02010;independent growth inhibitory activity.<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup> It has also been identified as an important TGF&#x02010;&#x003b2; receptor required for mediating TGF&#x02010;&#x003b2; growth inhibitory activity when canonical signaling mediated by T&#x003b2;R&#x02010;I and T&#x003b2;R&#x02010;II potentiates TGF&#x02010;&#x003b2; growth inhibitory activity (~100% at 1&#x02013;5&#x000a0;pM TGF&#x02010;&#x003b2;) in wild&#x02010;type Mv1Lu cells (7.9.10). To define the role of T&#x003b2;R&#x02010;V in mediating IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities, we determined the effects of T&#x003b2;R&#x02010;V antagonists such as a dual TGF&#x02010;&#x003b2;/IGFBP&#x02010;3 peptide antagonist (&#x003b2;<sub>1</sub>
<sup>25</sup>)<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0011" rid="fba21236-bib-0011" class=" bibr popnode">11</a></sup> and RAP, a LRP&#x02010;1 (T&#x003b2;R&#x02010;V) antagonist,<sup><a href="#fba21236-bib-0025" rid="fba21236-bib-0025" class=" bibr popnode">25</a></sup> and 10&#x000a0;nM insulin<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> on IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities in Mv1Lu cells, and wild&#x02010;type and LRP&#x02010;1 (T&#x003b2;R&#x02010;V)&#x02010;deficient Chinese hamster ovary (CHO) epithelial cells (CHO&#x02010;K1 and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells, respectively). As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2</span></a>, IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities in Mv1Lu cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2A,B,E</span></a>) and wild&#x02010;type CHO cells (CHO&#x02010;K1 cells) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2C</span></a>). Treatment of these cells with RAP or &#x003b2;<sub>1</sub>
<sup>25</sup> alone stimulated non&#x02010;specific (IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;independent) PPase activity (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2A,B</span></a>). Co&#x02010;treatment of these cells with RAP or &#x003b2;<sub>1</sub>
<sup>25</sup> and IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; stimulated non&#x02010;specific (IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;independent) PPase activity which was statistically indifferent from that treated with RAP or &#x003b2;<sub>1</sub>
<sup>25</sup> alone, suggesting that RAP or &#x003b2;<sub>1</sub>
<sup>25</sup> completely abolished the IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2A,B</span></a>, respectively). The important role of T&#x003b2;R&#x02010;V in mediating the IGFBP&#x02010;3&#x02010;stimulated PPase activity was further supported by experiments using CHO&#x02010;K1 and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2C,D</span></a>, respectively). IGFBP&#x02010;3 stimulated a PPase activity which was blocked in the presence of RAP in CHO&#x02010;K1 cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2C</span></a>). In Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2C</span></a>, the RAP alone value was taken as 0&#x000a0;cpm. It means that RAP alone, like vehicle only, exhibited non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity which was taken as a mean of 0&#x000a0;cpm (&#x000b1;SD, n&#x000a0;=&#x000a0;3). In Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2D</span></a>, both IGFBP&#x02010;3&#x02010; and RAP&#x02010;stimulated non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity in CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells which lacked the expression of LRP&#x02010;1 (T&#x003b2;R&#x02010;V) and did not exhibit IGFBP&#x02010;3&#x02010;stimulated PPase activity. IGFBP&#x02010;3 and RAP appeared to exert additive effects on stimulating non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity in CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2D</span></a>). However, deficiency of LRP&#x02010;1 appeared to greatly increase non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity up to ~10<sup>5</sup>&#x000a0;cpm activity baseline levels in these CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells as compared to those (10<sup>3</sup>&#x000a0;cpm activity baseline levels) seen in wild&#x02010;type CHO&#x02010;K1 cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2D</span></a> vs. Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2C</span></a>). LRP&#x02010;1 (T&#x003b2;R&#x02010;V) acts as a tumor suppressor for epithelial cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> Loss of LRP&#x02010;1 in CHO&#x02010;K1 cells leads to transformation into carcinoma cells (CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells) which exhibited a spindle&#x02010;shaped fibroblastoid morphology, frequently observed in invasive carcinoma cells.<sup><a href="#fba21236-bib-0015" rid="fba21236-bib-0015" class=" bibr popnode">15</a></sup> Transformation of wild&#x02010;type CHO epithelial cells into CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells (carcinoma cells) appeared to greatly upregulate non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity in these CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140772759264"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g005.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g005.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g005.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140772759264"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0002"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002">FIGURE 2</a></div><!--caption a7--><div class="caption"><p>IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities are inhibited by co&#x02010;treating cells with LRP&#x02010;1 (T&#x003b2;R&#x02010;V) antagonist (RAP), TGF&#x02010;&#x003b2; peptide antagonist (&#x003b2;<sub>1</sub>
<sup>25</sup>), or insulin in Mv1Lu (A, B, E) and CHO&#x02010;K1 (C) cells but not in CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> (D) cells. (A, B, E) Mv1Lu cells were treated with vehicle only, 1&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 or 40&#x000a0;pM TGF&#x02010;&#x003b2; in the presence or absence of RAP (60&#x000a0;&#x000b5;g/ml), &#x003b2;<sub>1</sub>
<sup>25</sup> (10&#x000a0;&#x000b5;g/ml), or insulin (10&#x000a0;nM). After 2&#x000a0;hr at 37&#x000b0;C, cell lysates were assayed for IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities as described above. (C, D) Wild&#x02010;type CHO (CHO&#x02010;K1) (C) and CHO&#x02010;LRP&#x02010;1&#x02010;null (CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup>) (D) cells were treated with vehicle only or 1&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 in the presence and absence of RAP (60&#x000a0;&#x000b5;g/ml). After 2&#x000a0;hr at 37&#x000b0;C, cell lysates were assayed for the IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity. The assays were performed in triplicates. The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly lower than that of cells treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; only: <em>p</em>&#x0003c;0.01 (A, B, C, E). Both IGFBP&#x02010;3&#x02010;and RAP&#x02010;stimulated non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity in CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells which lacked the expression of T&#x003b2;R&#x02010;V (LRP&#x02010;1) and did not exhibit T&#x003b2;R&#x02010;V&#x02010;mediated IGFBP&#x02010;3&#x02010;stimulated PPase activity (D). IGFBP&#x02010;3 and RAP exhibited the additive effects on stimulating non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity (which could be mediated by different non&#x02010;specific PPases in cell lysates) in CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells. Combination of insulin with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; also exhibited additive effects on stimulating non&#x02010;specific (IGFBP&#x02010;3&#x02010; or TGF&#x003b2;&#x02010;independent) PPase activity in Mv1Lu cells (E)</p></div></div></div><p class="p p-last">We previously demonstrated that insulin at 10&#x000a0;nM blocks IGFBP&#x02010;3&#x02010;induced growth inhibition in Mv1Lu cells<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup> and partially blocks TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in the presence of anti&#x02010;&#x003b1;5&#x003b2;1 integrin in these cells.<sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> We also demonstrated that insulin (10&#x000a0;nM)&#x02010;activated IGF&#x02010;1R catalyzes tyrosine&#x02010;phosphorylation of IRS&#x02010;1/2, conferring resistance of tyrosine&#x02010;phosphorylated IRS&#x02010;1/2 to IGFBP&#x02010;3&#x02010;stimulated dephosphorylation and IGFBP&#x02010;3&#x02010;induced growth inhibition in these cells.<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup> We hypothesize that IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases are involved in IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition, respectively, in target cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> We examined the effects of insulin on IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities. Mv1Lu cells were treated with insulin (10&#x000a0;nM) and IGFBP&#x02010;3 (0.3&#x000a0;&#x000b5;g/ml) or TGF&#x02010;&#x003b2; (50&#x000a0;pM) simultaneously for 2&#x000a0;hr. It is important to note that IGF&#x02010;1R&#x02010;catalyzed tyrosine phosphorylation of IRS&#x02010;1/2 occurs much faster than PPase&#x02010;catalyzed dephosphorylation of these proteins.<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> The IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity in the cell lysates of stimulated cells was determined using <sup>32</sup>P&#x02010;phosphorylated casein as a substrate. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2E</span></a>, insulin (10&#x000a0;nM), effectively attenuated IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activities in Mv1Lu cells. This is consistent with the notion that insulin&#x02010;stimulated IGF&#x02010;1R&#x02010;catalyzed tyrosine phosphorylation of IRS&#x02010;1/2 results in the inability of the tyrosine&#x02010;phosphorylated IRS&#x02010;1/2 to mediate activation of either IGFBP&#x02010;3&#x02010;stimulated PPase or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase in these cells treated with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2;.<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> Combination of insulin with IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; appeared to have additive effects on stimulating non&#x02010;specific (IGFBP&#x02010;3&#x02010;independent) PPase activity (in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0002/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0002" rid-ob="ob-fba21236-fig-0002" co-legend-rid="lgnd_fba21236-fig-0002"><span>2E</span></a>). These results support the notion that non&#x02010;tyrosine&#x02010;phosphorylated but Ser/Thr&#x02010;phosphorylated IRS&#x02010;1/2 are involved in T&#x003b2;R&#x02010;V&#x02010;mediated activation of IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated PPases, and in T&#x003b2;R&#x02010;V&#x02010;mediated cell growth inhibition by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup>
</p></div><div id="fba21236-sec-0016" class="sec"><h3 id="fba21236-sec-0016title">3.3. IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate colocalization of T&#x003b2;R&#x02010;V and IRS&#x02010;1/2 at the plasma membrane and cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 and IGFBP&#x02010;3&#x02010;stimulated PPase complexes in Mv1Lu cells</h3><p class="p p-first">We previously hypothesized that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; induce growth inhibition by interaction with T&#x003b2;R&#x02010;V, which recruits IRS&#x02010;1/2 and IGFBP&#x02010;3&#x02010;stimulated or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase to form ternary complexes at the cytoplasmic tail of T&#x003b2;R&#x02010;V, resulting in the activation of IGFBP&#x02010;3&#x02010;stimulated PPase or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase, dephosphorylation of IRS&#x02010;1/2 by activated IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase in the ternary complexes at the cytoplasmic tail of T&#x003b2;R&#x02010;V, dissociation of dephosphorylated IRS&#x02010;1/2&#x02010;IGFBP&#x02010;3&#x02010;stimulated PPase or dephosphorylated IRS&#x02010;1/2&#x02010;TGF&#x02010;&#x003b2;&#x02010;stimulated PPase binary complexes from the cytoplasmic tail of T&#x003b2;R&#x02010;V, and subsequent translocation of dephosphorylated IRS&#x02010;1/2&#x02010;IGFBP&#x02010;3&#x02010;stimulated PPase or dephosphorylated IRS&#x02010;1/2&#x02010;TGF&#x02010;&#x003b2;&#x02010;stimulated PPase binary complexes from cytoplasm to the nucleus where it induces cell cycle arrest by dephosphorylating retinoblastoma&#x02010;family proteins.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> To test this hypothesis, we performed immunofluorescence microscopy of Mv1Lu cells treated with and without (0.3&#x000a0;&#x000b5;g/ml) IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; using specific antibodies to T&#x003b2;R&#x02010;V/LRP&#x02010;1 and IRS&#x02010;1/2. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3A,B</span></a>, IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;&#x02010;stimulated colocalization of T&#x003b2;R&#x02010;V and IRS&#x02010;1/2 at the plasma membrane (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3A</span></a>f,i and Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3B</span></a>f,i, inset) and cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 but not IRS&#x02010;1 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3B</span></a>e,h vs. Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3A</span></a>e,h). These results suggest that IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; stimulate complex formation of T&#x003b2;R&#x02010;V, IRS&#x02010;1/2, and possibly IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;stimulated PPase at the plasma membrane and cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 likely as PPase complexes in Mv1Lu cells. To analyze the presence of IGFBP&#x02010;3&#x02010;stimulated PPase&#x02010;IRS&#x02010;2 complexes in nucleus extracts of Mv1Lu cells, the IGFBP&#x02010;3&#x02010;stimulated PPase activity associated with IRS&#x02010;2 in nucleus extracts was then determined. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3C</span></a>, IGFBP&#x02010;3 stimulated a PPase activity in cell lysates of treated Mv1Lu cells. Approximately 50% of it was present in nucleus extracts and could be immunoprecipitated by antibodies to IRS&#x02010;2 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3D</span></a> vs. Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3C</span></a>). Insulin completely abolished the IGFBP&#x02010;3&#x02010;stimulated PPase activity in cell lysates (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3C</span></a>). These results suggest that IGFBP&#x02010;3 stimulates complex formation and cytoplasm&#x02010;to&#x02010;nucleus translocation of IGFBP&#x02010;3&#x02010;stimulated PPase and IRS&#x02010;2 in Mv1Lu cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140765994128"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g006.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g006.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g006.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140765994128"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0003"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003">FIGURE 3</a></div><!--caption a7--><div class="caption"><p>IGFBP&#x02010;3 or TGF&#x02010;&#x003b2; stimulates co&#x02010;localization of T&#x003b2;R&#x02010;V and IRS&#x02010;1 (A) or IRS&#x02010;2 (B) at the plasma membrane and cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 (B), but not IRS&#x02010;1 (A), and cytoplasm (C)&#x02010;to&#x02010;nucleus (D) translocation of IRS&#x02010;2&#x02010;associated IGFBP&#x02010;3&#x02010;stimulated PPase activity in Mv1Lu cells. (A, B) Cells grown on coverslips in p35 culture dishes were treated with control (vehicle only), IGFBP&#x02010;3 (1&#x000a0;&#x000b5;g/ml) or TGF&#x02010;&#x003b2; (40&#x000a0;pM). K<sub>d</sub> for IGFBP&#x02010;3 and TGF&#x02010;&#x003b2; binding to T&#x003b2;R&#x02010;V were estimated to be 10&#x000a0;nM (0.3&#x000a0;&#x000b5;g/ml) and 50&#x000a0;pM, respectively.<sup><a href="#fba21236-bib-0003" rid="fba21236-bib-0003" class=" bibr popnode">3</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup> After 2&#x000a0;hr at 37&#x000b0;C, cells were fixed and stained by immunofluorescence using antibodies to T&#x003b2;R&#x02010;V and IRS&#x02010;1/2. Arrowheads indicate the co&#x02010;localization of T&#x003b2;R&#x02010;V and IRS&#x02010;1/2 at the plasma membrane (Af,i and Bf,i, inset); scale bar&#x000a0;=&#x000a0;10 microns. Both IGFBP&#x02010;3&#x02010; and TGF&#x02010;&#x003b2;&#x02010;stimulated cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 but not IRS&#x02010;1 (Be,h vs. Ae,h). (C,D) Cells were treated with IGFBP&#x02010;3 (1&#x000a0;&#x000b5;g/ml), insulin (10&#x000a0;nM), or insulin (10&#x000a0;nM) + IGFBP&#x02010;3 (1&#x000a0;&#x000b5;g/ml) for cell lysate assay, and with IGFBP&#x02010;3 (1&#x000a0;&#x000b5;g/ml) and vehicle only (&#x02010;&#x02010;&#x02010;) for nucleus extract assay. After 2&#x000a0;hr at 37&#x000b0;C, cell lysates (C) were assayed for IGFBP&#x02010;3&#x02010;stimulated PPase activity and nucleus extracts (D) were immunoprecipitated with control IgG and IgG to IRS&#x02010;2. The immunoprecipitates were then assayed for the IGFBP&#x02010;3&#x02010;stimulated PPase activity. The assays were performed in triplicates. The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly lower (C) or higher (D) than that of cells treated with IGFBP&#x02010;3 only or vehicle only: <em>p&#x000a0;</em>&#x0003c;&#x000a0;0.01</p></div></div></div></div><div id="fba21236-sec-0017" class="sec"><h3 id="fba21236-sec-0017title">3.4. IGFBP&#x02010;3&#x02010;induced growth inhibition, but not TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition, is reversed by OA and PP2A<sub>c</sub> siRNA in Mv1Lu and 32D cells</h3><p class="p p-first">Since OA blocked the activity of the IGFBP&#x02010;3&#x02010;stimulated PPase and the TGF&#x02010;&#x003b2;&#x02010;stimulated PPase activity was relatively resistant to inhibition by 0.2&#x02013;1&#x000a0;nM OA (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0001/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0001" rid-ob="ob-fba21236-fig-0001" co-legend-rid="lgnd_fba21236-fig-0001"><span>1D</span></a>), OA should be able to reverse IGFBP&#x02010;3&#x02010;induced growth inhibition, but not TGF&#x02010;&#x003b2;&#x02010;induce growth inhibition, in Mv1Lu cells. To test this, we determined the effects of OA on growth inhibition (as measured by [Methy&#x02010;<sup>3</sup>H] thymidine incorporation) induced by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4A</span></a>, OA reversed the growth inhibition induced by different concentrations of IGFBP&#x02010;3. OA reversed IGFBP&#x02010;3&#x02010;induced growth inhibition in a concentration&#x02010;dependent manner (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4A</span></a>). At 5&#x000a0;nM, OA reversed IGFBP&#x02010;3 (0.1&#x000a0;&#x003bc;g/ml)&#x02010;induced growth inhibition by ~80% (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4A</span></a>) but did not significantly affect TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in these cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4B</span></a>). IGFBP&#x02010;3&#x02010;stimulated PPase is sensitive to OA inhibition, suggesting that IGFBP&#x02010;3&#x02010;stimulated PPase is likely to be identical to PP2A which is known to be highly sensitive to OA.<sup><a href="#fba21236-bib-0026" rid="fba21236-bib-0026" class=" bibr popnode">26</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> To test this, we used murine myeloid cells which stably expressed human IR and IRS&#x02010;2 (32D cells) and responded to IGFBP&#x02010;3&#x02010;induced growth inhibition.<sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup> PP2A is a heterotrimer composed of a 36&#x02010;kDa catalytic C subunit (PP2A<sub>c</sub>), a 65&#x02010;kDa scaffolding A subunit, and a 56&#x02010;kDa substrate&#x02010;recognizing B subunit (PP2A&#x02010;B56).<sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> We examined the effect of PP2A<strong><sub>c</sub></strong> siRNA transfection on IGFBP&#x02010;3&#x02010;induced growth inhibition in these murine 32D cells. This PP2A<strong><sub>c</sub></strong> siRNA was developed based on the murine sequence. 32D cells were transfected with control siRNA, 2 and 4&#x000a0;nM PP2A<strong><sub>c</sub></strong> siRNA by electroporation and treated with IGFBP&#x02010;3. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4C,D</span></a>, PP2A<strong><sub>c</sub></strong> siRNA (2 and 4&#x000a0;nM) reversed the growth inhibition induced by IGFBP&#x02010;3 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4C</span></a>), but not by TGF&#x02010;&#x003b2; (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4D</span></a>), in a dose&#x02010;dependent manner in murine 32D cells. Four nM PP2A<strong><sub>c</sub></strong> siRNA reversed IGFBP&#x02010;3&#x02010;induced growth inhibition at 0.1&#x000a0;&#x003bc;g/ml by ~78% in these murine cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4C</span></a>). This degree of inhibition is comparable to the ~70% downregulation of PP2A<strong><sub>c</sub></strong> protein by murine PP2A<strong><sub>c</sub></strong> siRNA transfection (vs. control siRNA transfection) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4E</span></a>) as determined by 7.5% SDS&#x02010;PAGE followed by quantitative Western blot analysis of cell lysates from 32D cells transfected with control siRNA (&#x02010;) and 4&#x000a0;nM murine PP2A<strong><sub>c</sub></strong> siRNA (+) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4E</span></a>, top panel, lane 2 vs. lane 1 and bottom panel, quantitative analysis in three independent experiments). Murine PP2A<strong><sub>c</sub></strong> siRNA was unable to reverse IGFBP&#x02010;3&#x02010;induced growth inhibition in mink Mv1Lu cells (data not shown). This is consistent with the inability of murine PP2A<strong><sub>c</sub></strong> siRNA to significantly downregulate mink PP2A<strong><sub>c</sub></strong> (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><span>4E</span></a>, top panel, lane 4 vs. lane 3). These results suggest that IGFBP&#x02010;3&#x02010;induced growth inhibition is reversed by OA in Mv1Lu cells and by murine PP2A<sub>c</sub> siRNA in murine 32D cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0004" co-legend-rid="lgnd_fba21236-fig-0004"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140774752288"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g001.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g001.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g001.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140774752288"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0004"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0004/" target="figure" rid-figpopup="fba21236-fig-0004" rid-ob="ob-fba21236-fig-0004">FIGURE 4</a></div><!--caption a7--><div class="caption"><p>IGFBP&#x02010;3&#x02010; but not TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition is reversed by OA in Mv1Lu cells (A, B) and by PP2A<sub>c</sub> siRNA in 32D cells (C, D) via attenuating PP2A<sub>c</sub> expression in these cells (E). (A,B) Mv1Lu cells were treated with several concentrations of OA for 1&#x000a0;hr at 37&#x000b0;C and then treated with several concentrations IGFBP&#x02010;3 (A) or TGF&#x02010;&#x003b2; (B). After 18&#x000a0;hr at 37&#x000b0;C, the cell growth was determined by measurement of [methy&#x02010;<sup>3</sup>H] thymidine incorporation into cellular DNA. The [methy&#x02010;<sup>3</sup>H] thymidine incorporation in cells incubated without OA was taken as 100% cell growth. The reversibility (%) by OA of IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition was estimated by 100 &#x000d7; (IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in the absence of OA &#x02013; IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in the presence of OA)/IGFBP&#x02010;3&#x02010; or TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in the absence of OA). The assays were performed in triplicates. The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly lower than that of cells treated with control (vehicle only) (A): <em>p&#x000a0;</em>&#x0003c;&#x000a0;0.01. (C,D)&#x0200b; 32D cells were transfected with 0, 2, and 4&#x000a0;nM (C) or 0 and 4&#x000a0;nM (D) murine PP2A<sub>c</sub> siRNA by electroporation. Transfected cells were treated with several concentrations of IGFBP&#x02010;3 (C) or TGF&#x02010;&#x003b2; (D). After 18&#x000a0;hr at 37&#x000b0;C, the cell growth was determined by measurement of [methy&#x02010;<sup>3</sup>H] thymidine incorporation into cellular DNA. The cell growth in cells treated with control siRNA (control) was taken as 100% (C, D). The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly lower than that of cells treated with control siRNA (control) (C): <em>p</em>&#x000a0;&#x0003c;&#x000a0;0.01. (E) Murine PP2A<sub>c</sub> siRNA attenuates the expression of PP2A<sub>c</sub> protein in murine 32D cells but not in mink Mv1Lu cells. 32D and Mv1Lu cells were transfected with control siRNA (&#x02212;) and 4&#x000a0;nM murine PP2A<sub>c</sub> siRNA (+) by electroporation. Transfected cells were analyzed by Western blot analysis using antibody to PP2A<sub>c</sub> (top panel), which were representatives of a total of three experiments, and quantified by densitometry (bottom panel). Murine PP2A<sub>c</sub> siRNA was effective in attenuating PP2A<sub>c</sub> expression in 32D cells (murine cells) (top panel, lane 2 vs. lane 1) but not in Mv1Lu cells (mink lung cells) (top panel, lane 4 vs. lane 3). The analysis was performed in triplicates. The data are mean&#x000a0;&#x000b1;&#x000a0;SD *Significantly lower than that of cells treated with control siRNA (&#x02212;): <em>p&#x000a0;</em>&#x0003c;&#x000a0;0.01</p></div></div></div></div><div id="fba21236-sec-0018" class="sec"><h3 id="fba21236-sec-0018title">3.5. IGFBP&#x02010;3 stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A in Mv1Lu cells</h3><p class="p p-first">As described above, IGFBP&#x02010;3&#x02010;stimulated PPase activity and IGFBP&#x02010;3&#x02010;induced growth inhibition are blocked or reversed by co&#x02010;treatment with very low concentrations of OA in Mv1Lu and 32D cells and by transfection with PP2A<strong><sub>c</sub></strong> siRNA in murine 32D cells. These suggest that the IGFBP&#x02010;3&#x02010;stimulated PPase is identical to PP2A. We hypothesized that IGFBP&#x02010;3 induces growth inhibition by stimulating IRS&#x02010;2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<strong><sub>c</sub></strong> in Mv1Lu cells. To test this, Mv1Lu cells were treated with 0, 2, and 10&#x000a0;nM (or 0.06 and 0.3&#x000a0;&#x000b5;g/ml, respectively), IGFBP&#x02010;3 for 2&#x000a0;hr. The cytoplasm and nucleus fractions in treated cells were then isolated and subjected to 7.5% SDS&#x02010;PAGE followed by Western blot analysis. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005" co-legend-rid="lgnd_fba21236-fig-0005"><span>5A</span></a>, IGFBP&#x02010;3 at 2 and 10&#x000a0;nM increased accumulation of PP2A<strong><sub>c</sub></strong> in the nucleus fraction by 1.5&#x02010; to 1.7&#x02010;fold (n = 3) as compared to that in cells treated with vehicle only (0&#x000a0;nM IGFBP&#x02010;3). These results suggest that IGFBP&#x02010;3 promotes cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<strong><sub>c</sub></strong> (likely as the IRS&#x02010;2 complex) in Mv1Lu cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0005" co-legend-rid="lgnd_fba21236-fig-0005"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140764974912"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g002.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g002.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g002.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140764974912"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0005"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005">FIGURE 5</a></div><!--caption a7--><div class="caption"><p>IGFBP&#x02010;3 stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<sub>c</sub> in Mv1Lu cells (A) and inhibits growth by inducing dephosphorylation of pRb&#x02010;related proteins, p130 and p107, in Mv1Lu (B) and 32D (C) cells, respectively. Mv1Lu cells were treated with 0, 2, and 10&#x000a0;nM (or 0, 0.06 and 0.3&#x000a0;&#x000b5;g/ml, respectively), IGFBP&#x02010;3 for 2&#x000a0;hr. The cytoplasm and nucleus fractions were separated by centrifugation and analyzed by 7.5% SDS&#x02010;PAGE followed by Western blot analysis using antibodies to PP2A<sub>c</sub>, &#x003b2;&#x02010;actin, and lamin B. The final volume of the total cytoplasm fraction was 10 times higher than that of the total nucleus fraction. However, an equal volume of cytoplasm and nucleus fractions was analyzed by 7.5% SDS&#x02010;PAGE followed by Western blot analysis. At 2 and 10&#x000a0;nM, IGFBP&#x02010;3 appeared to increase cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A<sub>c</sub> by ~2 fold. Western blot analysis was the representative of a total of three experiments. Lamin B and &#x003b2;&#x02010;actin served as nuclear and cytoplasmic internal standards, respectively. (B and C) Mv1Lu (B) and 32D (C) cells were pre&#x02010;incubated with [<sup>32</sup>P]&#x02010;orthophosphate for 2&#x000a0;hr, washed and incubated in the culture medium with excess phosphate. <sup>32</sup>P&#x02010;labeled cells were treated with vehicle only or 0.3&#x000a0;&#x000b5;g/ml of IGFBP&#x02010;3 in the presence and absence of OA (5&#x000a0;nM) and RAP (60&#x000a0;&#x000b5;g/ml). After 2&#x000a0;hr at 37&#x000b0;C, cell lysates were immunoprecipitated with antibodies to p130 and p107. The immunoprecipitates were analyzed by 7.5% SDS&#x02010;PAGE and quantified by a Perkin Elmer phosphorimager (B and C, panels a and b). Phosphorimager analysis was the representative of a total of three experiments. IGFBP&#x02010;3 appeared to stimulate dephosphorylation of p130 and p107 in Mv1Lu and 32D cells, respectively (B and C, panels a, lane 2 vs. lane 1 and panel b, quantitative data). OA and RAP inhibited IGFBP&#x02010;3&#x02010;stimulated dephosphorylation of p130 and p107 (B and C, panel a, lanes 3 and 4 vs. lane 2 and panel b, quantitative data) in Mv1Lu and 32D cells, respectively. The quantitative data from three independent analyses were shown. The data are mean &#x000b1;SD *Significantly lower than that of cells treated with vehicle only (control): <em>p&#x000a0;</em>&#x0003c;&#x000a0;0.01</p></div></div></div></div><div id="fba21236-sec-0019" class="sec"><h3 id="fba21236-sec-0019title">3.6. IGFBP&#x02010;3 inhibits growth by inducing dephosphorylation of pRb&#x02010;related proteins, p130 and p107, in Mv1Lu and 32D cells, respectively</h3><p class="p p-first-last">PP2A plays a critical multi&#x02010;faceted role in the regulation of the cell cycle. It has been implicated in dephosphorylation of two retinoblastoma protein (pRb)&#x02010;related proteins, p130 and p107, which interact primarily with E2F4 and E2F5 and are most active in G0&#x02010;the quiescent phase of the cell cycle.<sup><a href="#fba21236-bib-0026" rid="fba21236-bib-0026" class=" bibr popnode">26</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> Moreover, pRb (p105) interacts primarily with E2F1&#x02013;3 and is most active at the G1&#x02010;to&#x02010;S phase transition.<sup><a href="#fba21236-bib-0026" rid="fba21236-bib-0026" class=" bibr popnode">26</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> These suggest that IRS&#x02010;2&#x02010;PP2A complexes may dephosphorylate pRb&#x02010;related proteins (p130 and p107) in the nucleus of target cells. To test this possibility, Mv1Lu and 32D cells were pre&#x02010;labeled with <sup>32</sup>P&#x02010;orthophosphate at 37&#x000b0;C for 1&#x000a0;hr, washed, and incubated with 0.3&#x000a0;&#x000b5;g/ml (10&#x000a0;nM) IGFBP&#x02010;3 in the presence of excess unlabeled orthophosphate in the medium. After 2&#x000a0;hr at 37&#x000b0;C, <sup>32</sup>P&#x02010;labeled cell lysates were immunoprecipitated with specific antibodies to p130 and p107 and analyzed by 7.5% SDS&#x02010;PAGE and quantified by a phosphorimager (panels a and b, respectively). As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005" co-legend-rid="lgnd_fba21236-fig-0005"><span>5B</span></a> and Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005" co-legend-rid="lgnd_fba21236-fig-0005"><span>5C</span></a>, IGFBP&#x02010;3&#x02010;induced dephosphorylation of p130 and p107 in Mv1Lu and 32D cells, respectively (panel a, lane 2 vs. lane 1 and panel b, quantitative analysis from three experiments). The IGFBP&#x02010;3&#x02010;induced dephosphorylation of p130 and p107 was blocked in these cells co&#x02010;treated with OA and RAP (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0005/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0005" rid-ob="ob-fba21236-fig-0005" co-legend-rid="lgnd_fba21236-fig-0005"><span>5B,C</span></a>, panel a, lanes 3 and 4 vs. lane 2 and panel b, quantitative analysis from three experiments).</p></div><div id="fba21236-sec-0020" class="sec"><h3 id="fba21236-sec-0020title">3.7. TGF&#x02010;&#x003b2; induces colocalization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> at the plasma membrane and accumulation of PP1 and decreased levels of hyperphosphorylated pRb (P&#x02010;Rb) in the nucleus in Mv1Lu cells</h3><p class="p p-first">The TGF&#x02010;&#x003b2;&#x02010;stimulated PPase involved in TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition has been identified as PP1 in human keratinocytes.<sup><a href="#fba21236-bib-0028" rid="fba21236-bib-0028" class=" bibr popnode">28</a></sup> PP1 is responsible for dephosphorylating of pRb (p105) which is linked to TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in Mv1Lu cells.<sup><a href="#fba21236-bib-0029" rid="fba21236-bib-0029" class=" bibr popnode">29</a></sup> The mechanism by which TGF&#x02010;&#x003b2; stimulates PP1 activity is not clear. Since TGF&#x02010;&#x003b2; induces growth inhibition by stimulating complex formation of T&#x003b2;R&#x02010;V, IRS&#x02010;1/2, and likely PP1 at the plasma membrane in Mv1Lu cells, we hypothesize that PP1 should be activated by its interaction with IRS&#x02010;1/2 in the formation of the T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;1/2&#x02010;PP1 ternary complexes in TGF&#x02010;&#x003b2;&#x02010;treated cells. PP1 enzyme contains both a 37&#x02010;kDa catalytic subunit (PP1<sub>c</sub>) and at least one regulatory subunit which directs PP1<sub>c</sub> to different substrates or sites. To test this, we performed immunofluorescence microscopy in Mv1Lu cells treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; at 37&#x002da;C for 0 and 1&#x000a0;hr using antibodies to T&#x003b2;R&#x02010;V (LRP&#x02010;1) and PP1<sub>c</sub> (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6A</span></a>). TGF&#x02010;&#x003b2;&#x02010;stimulated colocalization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> at the plasma membrane, as indicated by arrowheads in Mv1Lu cells treated with TGF&#x02010;&#x003b2; at 37&#x002da;C for 1&#x000a0;hr (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6A</span></a>f). In contrast, Mv1Lu cells treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; for 0&#x000a0;hr did not exhibit colocalization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> in these cells (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6A</span></a>c).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140772149296"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g008.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g008.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g008.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140772149296"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0006"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006">FIGURE 6</a></div><!--caption a7--><div class="caption"><p>TGF&#x02010;&#x003b2; induces co&#x02010;localization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> at the plasma membrane (A) and accumulation of PP1<sub>c</sub> and decreased levels of hyperphosphorylated pRb (P&#x02010;Rb) in the nucleus (B) in Mv1Lu cells. Mv1Lu cells were grown to 50% confluence on coverslips in 35&#x000a0;mm culture dishes at 37&#x002da;C for 24&#x000a0;hr. Mv1Lu cells were then treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; at 37&#x000b0;C. After 0 and 1&#x000a0;hr (A) or 0, 1, and 2&#x000a0;hr (B), cells were fixed and stained by immunofluorescence using antibodies to T&#x003b2;R&#x02010;V and PP1<sub>c</sub> (A) or using antibodies to PP1<sub>c</sub> and P&#x02010;Rb (B). (A) After immunofluorescence staining, cells on coverslips were counted. Cells treated with TGF&#x02010;&#x003b2; at 37&#x000b0;C for 0&#x000a0;hr did not exhibit colocalization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> at the plasma membrane (Ac). However, cells treated with TGF&#x02010;&#x003b2; at 37&#x000b0;C for 1&#x000a0;hr exhibited colocalization of T&#x003b2;R&#x02010;V and PP1<sub>c</sub> at the plasma membrane as indicated by arrowheads (Af). T&#x003b2;R&#x02010;V (LRP&#x02010;1) is known to undergo constitutive endocytosis and recycling in cells. Perinuclear labeling is likely to be endocytic vesicles which are often seen in juxtanuclear regions. This appearance of endocytic vesicles might be due to longer&#x02010;time cell culture before the experiment. (B) After treatment of cells with TGF&#x02010;&#x003b2; for 1 or 2&#x000a0;hr at 37&#x000b0;C, approximately 40%&#x02013;50% cells on a coverslip exhibited significantly decreased yellow fluorescence (co&#x02010;localization) in the nucleus, whereas ~90% cells (treated with TGF&#x02010;&#x003b2; at 37&#x000b0;C for 0&#x000a0;hr) on a coverslip exhibited yellow fluorescence (colocalization) in the nucleus (Bf,i and Bc, respectively). Arrowheads indicate decreased colocalization (as marked by decreased yellow fluorescence) of PP1<sub>c</sub> and P&#x02010;Rb (Bf,i) due to decreased P&#x02010;Rb (as marked by decreased red fluorescence) in the nucleus (Be,h)</p></div></div></div><p class="p p-last">Retinoblastoma protein (pRb) present in the cytoplasm and nucleus fractions are identified as hyperphosphorylated (as a slow&#x02010;migrating form) and hypophosphorylated (as a fast&#x02010;migrating form) forms of pRb, respectively, based on its mobility on 7.5% SDS&#x02010;PAGE.<sup><a href="#fba21236-bib-0029" rid="fba21236-bib-0029" class=" bibr popnode">29</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0030" rid="fba21236-bib-0030" class=" bibr popnode">30</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0031" rid="fba21236-bib-0031" class=" bibr popnode">31</a></sup> Cytoplasmic pRb is known to be mainly the hyperphosphorylated form.<sup><a href="#fba21236-bib-0032" rid="fba21236-bib-0032" class=" bibr popnode">32</a></sup> These suggest that TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub> and correspondingly increases the amount of hypophosphorylated pRb (as a fast&#x02010;migrating form of pRb on 7.5% SDS&#x02010;PAGE), which is the PP1<sub>c</sub>&#x02010;dephosphorylated product of pRb in the nucleus. To demonstrate the subsequent cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub> and its effect on dephosphorylation of pRb in the nucleus, we performed immunofluorescence analysis in Mv1Lu cells treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; at 37&#x002da;C for 0, 1, and 2&#x000a0;hr using specific antibodies to PP1<sub>c</sub> and hyperphosphorylated pRb (P&#x02010;Rb). We reasoned that TGF&#x02010;&#x003b2; promotes nucleus accumulation of PP1<sub>c</sub> and should accordingly decrease the amount of P&#x02010;Rb, its target substrate, in the nucleus. PP1 specifically dephosphorylates pRb in the nucleus of target cells.<sup><a href="#fba21236-bib-0028" rid="fba21236-bib-0028" class=" bibr popnode">28</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0029" rid="fba21236-bib-0029" class=" bibr popnode">29</a></sup> After treatment of cells with TGF&#x02010;&#x003b2; and immunofluorescence staining, six images, which consist of 6&#x02013;8 cells/image, were taken at different areas of cells grown on a coverslip. The image shown in the data was the representative of the six images. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6B</span></a>, after treatment of cells with TGF&#x02010;&#x003b2; at 37&#x002da;C for 1 or 2&#x000a0;hr, approximately 40%&#x02013;50% cells on a coverslip exhibited significantly decreased yellow fluorescence (co&#x02010;localization) in the nucleus, whereas ~90% cells (treated with TGF&#x02010;&#x003b2; at 37&#x002da;C for 0&#x000a0;hr) on a coverslip exhibited yellow fluorescence (colocalization) in the nucleus (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6B</span></a>f,i and Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6B</span></a>c, respectively). TGF&#x02010;&#x003b2; treatment of cells for 1 and 2&#x000a0;hr decreased the amount of P&#x02010;Rb and colocalization of PP1<sub>c</sub> and P&#x02010;Rb in the nucleus (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6B</span></a>e,h and Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0006/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0006" rid-ob="ob-fba21236-fig-0006" co-legend-rid="lgnd_fba21236-fig-0006"><span>6B</span></a>f,i, respectively). These results support the suggestion that TGF&#x02010;&#x003b2; promotes cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub>, resulting in dephosphorylation of pRb in the nucleus, which leads to cell growth arrest.</p></div><div id="fba21236-sec-0021" class="sec sec-last"><h3 id="fba21236-sec-0021title">3.8. TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub> and increases formation of dephosphorylated pRb (Rb) in the nucleus in Mv1Lu (A) and A549 (B) cells</h3><p class="p p-first">To further support the hypothesis that TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1, we determined the subcellular localization of PP1<sub>c</sub>, PP2A<sub>c</sub>, pRb (Rb), phosphorylated Smad2 (P&#x02010;Smad2), phosphorylated IRS&#x02010;1/2 (P&#x02010;IRS&#x02010;1/2, phosphorylation at Ser 270), lamin B, and &#x003b2;&#x02010;actin using 7.5% SDS&#x02010;PAGE and quantitative Western blot analysis with specific antibodies to PP1<sub>c</sub>, PP2A<sub>c</sub>, and others after subcellular cytoplasm/nucleus fractionation of Mv1Lu and A549 cells treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; for 0, 1, and 2&#x000a0;hr. As shown in Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><span>7</span></a>, TGF&#x02010;&#x003b2; increased the amounts of PP1<sub>c</sub> (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><span>7A,B</span></a>), dephosphorylated Rb (as a fast&#x02010;migrating form of Rb on 7.5% SDS&#x02010;PAGE) (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><span>7A,B</span></a>), P&#x02010;IRS&#x02010;2 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><span>7A</span></a>), and P&#x02010;Smad2 (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><span>7A,B</span></a>) in the nucleus fraction in a time&#x02010;dependent manner in these cells. Both P&#x02010;IRS&#x02010;1/2 contain Ser 270 but only P&#x02010;IRS&#x02010;2 entered the nucleus (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0003/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0003" rid-ob="ob-fba21236-fig-0003" co-legend-rid="lgnd_fba21236-fig-0003"><span>3B</span></a>e,h). After 2&#x000a0;hr, TGF&#x02010;&#x003b2; increased the amounts of PP1<sub>c</sub>, dephosphorylated Rb (as a fast migrating form on 7.5% SDS&#x02010;PAGE), P&#x02010;IRS&#x02010;2 and P&#x02010;Smad2 by 1.5&#x02010; to 2&#x02010;fold (n&#x000a0;=&#x000a0;3) in the nucleus fraction in Mv1Lu and A549 cells. In contrast, TGF&#x02010;&#x003b2; did not significantly increase the amount of PP2A<sub>c</sub> in the nucleus fraction in these cells. Interestingly, Rb present in the cytoplasm and nucleus fractions were identified as phosphorylated (as a slow&#x02010;migrating form) and dephosphorylated (as a fast&#x02010;migrating form) forms of Rb, respectively, based on its mobility on 7.5% SDS&#x02010;PAGE.<sup><a href="#fba21236-bib-0029" rid="fba21236-bib-0029" class=" bibr popnode">29</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0030" rid="fba21236-bib-0030" class=" bibr popnode">30</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0031" rid="fba21236-bib-0031" class=" bibr popnode">31</a></sup> Cytoplasmic Rb is known to be mainly the hyperphosphorylated form.<sup><a href="#fba21236-bib-0032" rid="fba21236-bib-0032" class=" bibr popnode">32</a></sup> These results suggest that TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub> and P&#x02010;IRS&#x02010;2, and correspondingly increases the amount of dephosphorylated Rb (as a fast&#x02010;migrating form of Rb), which is the PP1&#x02010;dephosphorylated product of Rb, in the nucleus.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0007" co-legend-rid="lgnd_fba21236-fig-0007"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140812668736"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g007.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g007.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g007.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140812668736"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0007"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0007/" target="figure" rid-figpopup="fba21236-fig-0007" rid-ob="ob-fba21236-fig-0007">FIGURE 7</a></div><!--caption a7--><div class="caption"><p>TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub> in Mv1Lu (A) and A549 (B) cells and increases dephosphorylated pRb (a fast&#x02010;migrating form of pRb) levels in the nucleus in these cells. Mv1Lu (A) and A549 (B) cells were treated with 40&#x000a0;pM TGF&#x02010;&#x003b2; for 0, 1, and 2&#x000a0;hr. The cytoplasm and nucleus fractions were separated by centrifugation and analyzed by 7.5% SDS&#x02010;PAGE followed by quantitative Western blot analysis using antibodies to PP1<sub>c</sub>, PP2A<sub>c</sub>, pRb (Rb), P&#x02010;IRS&#x02010;1/2 (phosphorylated IRS&#x02010;1/2, Ser 270), P&#x02010;Smad2 (phosphorylated Smad2), lamin B, and &#x003b2;&#x02010;actin. pRb (Rb) (present in the nucleus) migrated as a fast&#x02010;migrating form (dephosphorylated pRb) on 7.5% SDS&#x02010;PAGE. pRb (Rb) (present in the cytoplasm) migrated as a slow form (phosphorylated pRb). The final volume of the total cytoplasm fraction was 10 times higher than that of the total nucleus fraction. An equal volume of cytoplasm and nucleus fractions was then analyzed by 7.5% SDS&#x02010;PAGE followed by Western blot analysis. Western blots were representatives of a total of three experiments. Lamin B and &#x003b2;&#x02010;actin served as nuclear and cytoplasmic internal standards, respectively</p></div></div></div></div></div><div id="fba21236-sec-0022" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0022title">4. DISCUSSION</h2><p class="p p-first">Here, we have provided evidence revealing that IGFBP&#x02010;3 inhibits growth in epithelial cells by stimulating the T&#x003b2;R&#x02010;V&#x02010;mediated growth inhibition signaling cascade which involves IRS&#x02010;2, PP2A, and pRb&#x02010;related proteins, p130 or p107. We propose a revised version of our previously published model<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> to demonstrate the molecular mechanism of IGFBP&#x02010;3&#x02010;induced growth inhibition in epithelial cells and other cell types. In this model (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><span>8A</span></a>), IGFBP&#x02010;3 is a non&#x02010;covalently linked homodimeric protein. It binds to T&#x003b2;R&#x02010;V by interaction with its cell surface subdomains II and IV,<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> resulting in dimerization of T&#x003b2;R&#x02010;V and subsequent recruitment of Ser/Thr&#x02010;phosphorylated IRS&#x02010;1 or IRS&#x02010;2 and then PP2A to the cytoplasmic tail of the dimeric T&#x003b2;R&#x02010;V. Interacting proteins or specific protein substrates of PP2A are known to possess PP2A&#x02010;B56 docking (or binding) motifs (L/MxxL/I/VxE) which contain contiguous six amino acid residues and are well conserved throughout the eukaryotic domain of life and in human viruses.<sup><a href="#fba21236-bib-0033" rid="fba21236-bib-0033" class=" bibr popnode">33</a></sup> IRS&#x02010;1 and IRS&#x02010;2 possess PP2A&#x02010;B56 docking motifs of LytrdE (residues 86&#x02013;91) and LkeLfE (residues 294&#x02013;299), respectively, which provide binding sites for PP2A&#x02010;B56 (binding affinity: IRS&#x02010;2&#x000a0;&#x0003e;&#x000a0;IRS&#x02010;1). PP2A in the T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;1&#x02010;PP2A or T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;2&#x02010;PP2A ternary complex becomes activated and dephosphorylates IRS&#x02010;1 or IRS&#x02010;2 in the complex, leading to dissociation of dephosphorylated IRS&#x02010;1&#x02010;PP2A or IRS&#x02010;2&#x02010;PP2A binary complexes from the cytoplasmic tail of T&#x003b2;R&#x02010;V (at the plasma membrane). High&#x02010;affinity&#x02010;bound dephosphorylated IRS&#x02010;2&#x02010;PP2A complexes then undergo IRS&#x02010;2&#x02010;dependent translocation from cytoplasm to the nucleus where activated PP2A dephosphorylates pRb&#x02010;related proteins, p130 and p107, resulting in growth arrest. p130 and p107 possess high&#x02010;affinity PP2A&#x02010;B56 docking motifs of LsgIlE (residues 519&#x02013;524) and LinIfE (residues 412&#x02013;417), respectively. It is important to note that p130 and p107 do not possess specific PP1<sub>c</sub> docking motifs (FxxR/KxR/K),<sup><a href="#fba21236-bib-0034" rid="fba21236-bib-0034" class=" bibr popnode">34</a></sup> suggesting that p130 and p107 are the PP2A target substrates in the nucleus. In this communication, we also demonstrate that IGFBP&#x02010;3 stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 but not IRS&#x02010;1. IRS&#x02010;2&#x000a0;has been shown to undergo nuclear translocation in normal and cancer cells.<sup><a href="#fba21236-bib-0035" rid="fba21236-bib-0035" class=" bibr popnode">35</a></sup> It possesses a putative nuclear localization signal (NLS) motif of KKwRsK (residues 80&#x02013;85). Moreover, after dissociation from the cytoplasmic tail of T&#x003b2;R&#x02010;V, low&#x02010;affinity&#x02010;bound dephosphorylated IRS&#x02010;1&#x02010;PP2A complexes are mainly present in the cytoplasm and do not have known functions in cells treated with IGFBP&#x02010;3.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> However, IGFBP&#x02010;3 is known to inhibit phosphorylation of c&#x02010;raf&#x02010;MEK&#x02010;ERK and p38 kinase in insulin&#x02010;secreting cells.<sup><a href="#fba21236-bib-0036" rid="fba21236-bib-0036" class=" bibr popnode">36</a></sup> PP2A is also known to inhibit the kinase activities of the kinases involved in T&#x003b2;R&#x02010;I&#x02010;activated non&#x02010;Smad pathways, which include JNK,<sup><a href="#fba21236-bib-0037" rid="fba21236-bib-0037" class=" bibr popnode">37</a></sup> TAK1&#x02010;p38/JNK,<sup><a href="#fba21236-bib-0038" rid="fba21236-bib-0038" class=" bibr popnode">38</a></sup> PI3K&#x02010;AKT,<sup><a href="#fba21236-bib-0039" rid="fba21236-bib-0039" class=" bibr popnode">39</a></sup> and RhoA&#x02010;Rock<sup><a href="#fba21236-bib-0040" rid="fba21236-bib-0040" class=" bibr popnode">40</a></sup> signaling, by dephosphorylating these kinases.<sup><a href="#fba21236-bib-0041" rid="fba21236-bib-0041" class=" bibr popnode">41</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0042" rid="fba21236-bib-0042" class=" bibr popnode">42</a></sup> It is likely that IRS&#x02010;1&#x02010;PP2A is responsible, at least in part, for IGFBP&#x02010;3&#x02010;induced inhibition of non&#x02010;Smad signaling.<sup><a href="#fba21236-bib-0036" rid="fba21236-bib-0036" class=" bibr popnode">36</a></sup>
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140140773147680"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g004.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is FBA2-3-709-g004.jpg" src="/pmc/articles/PMC8409558/bin/FBA2-3-709-g004.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140140773147680"><a target="object" rel="noopener" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fba21236-fig-0008"><div><a class="figpopup" href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008">FIGURE 8</a></div><!--caption a7--><div class="caption"><p>Models for the mechanisms by which IGFBP&#x02010;3 (A) and TGF&#x02010;&#x003b2; (B) induces cellular growth inhibition and the cross talk between T&#x003b2;R&#x02010;V and IR/IGF&#x02010;1R signaling (A, B). (A)&#x0200b; IGFBP&#x02010;3 induces growth inhibition by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;2&#x02010;dependent activation and cytoplasm&#x02010;to&#x02010;nucleus translocation of PP2A, resulting in dephosphorylation of pRb&#x02010;related proteins (p130 and p107). In the IGFBP&#x02010;3&#x02010;stimulated tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP2A/p107, p130), T&#x003b2;R&#x02010;V is identical to LRP&#x02010;1 which has a 515&#x02010;kDa &#x003b1; chain that contains four cell surface ligand&#x02010;binding subdomains (I, II, III, and IV) and an 85&#x02010;kDa &#x003b2; chain comprising the transmembrane domain and cytoplasmic tail. IGFBP&#x02010;3 binds to cell surface subdomains II and IV of T&#x003b2;R&#x02010;V. Insulin and IGF&#x02010;I antagonize IGFBP&#x02010;3&#x02010;induced cellular growth inhibition by stimulating tyrosine phosphorylation of IRS&#x02010;1/2 via interaction with their cognate receptors. The signaling cascades potentiated in diabetic patients are indicated by red arrows. Under non&#x02010;insulin&#x02010;stimulating conditions, IRS&#x02010;1/2 are mainly phosphorylated at serine residues. (B) In epithelial cells, TGF&#x02010;&#x003b2; induces potent growth inhibition (100% growth inhibition at 1&#x02013;5&#x000a0;pM) by stimulating the T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;2&#x02010;dependent tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) in concert with canonical TGF&#x02010;&#x003b2; signaling mediated by T&#x003b2;R&#x02010;I and T&#x003b2;R&#x02010;II (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad&#x02010;2/3/4). The T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) is essential to dephosphorylate (activate) pRb (by PP1) for causing TGF&#x02010;&#x003b2; growth inhibition. T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical signaling is required for potentiating TGF&#x02010;&#x003b2; growth inhibition (mediated by T&#x003b2;R&#x02010;V) by transcriptional activation of CDK inhibitors<sup><a href="#fba21236-bib-0014" rid="fba21236-bib-0014" class=" bibr popnode">14</a></sup> which activate the T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb cascade via maintaining pRb unphosphorylated (active) in the nucleus.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> TGF&#x02010;&#x003b2; also stimulates IRS&#x02010;1&#x02010;dependent activation and formation of PP1&#x02010;PP2A complexes which target and suppress T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad pathways. The T&#x003b2;R&#x02010;I is present as T&#x003b2;R&#x02010;V&#x02013;T&#x003b2;R&#x02010;I complexes<sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup> mainly localized in plasma&#x02010;membrane non&#x02010;lipid raft microdomains. In normal epithelial cells, which express T&#x003b2;R&#x02010;V, TGF&#x02010;&#x003b2;, as a tumor suppressor, suppresses carcinogenesis by potently inhibiting cell growth in normal epithelial cells via stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;2&#x02010;dependent tumor suppressor signaling (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) in concert with canonical TGF&#x02010;&#x003b2; signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad&#x02010;2/3/4) and by suppressing T&#x003b2;R&#x02010;I&#x02010;mediated tumor progression via stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;1&#x02010;dependent signaling (T&#x003b2;R&#x02010;V/IRS&#x02010;1/PP1&#x02010;PP2A/T&#x003b2;R&#x02010;I). Insulin and IGF&#x02010;I antagonize TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;V/IRS&#x02010;1/2/PP1 signaling by stimulating tyrosine phosphorylation of IRS&#x02010;1/2 via interaction with their cognate receptors, insulin receptor (IR), and IGF&#x02010;1 receptor (IGF&#x02010;1R). The tyrosine phosphorylation of IRS&#x02010;1/2 catalyzed by IR and IGF&#x02010;1 receptor, which occurs more rapidly than the Ser/Thr&#x02010;specific dephosphorylation of IRS&#x02010;1/2 by PP1 or PP2A, leads to multiple IR/IGF&#x02010;1R downstream signaling pathways and prevents the formation of T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;1/2&#x02010;PP1 complexes. Tyrosine phosphorylation and Ser/Thr&#x02010;specific dephosphorylation of IRS&#x02010;1/2 are mutually exclusive.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> In diabetes, insulin or insulin signaling defects potentiate TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in target cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> In addition, high glucose in the plasma and tissues of diabetic patients may enhance T&#x003b2;R&#x02010;V and T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II signaling via increasing TGF&#x02010;&#x003b2; production and T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II expression.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0080" rid="fba21236-bib-0080" class=" bibr popnode">80</a></sup> Increased ECM synthesis (which is mediated by T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling) further attenuates insulin signaling and enhances TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition,<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> resulting in alopecia, impaired wound healing, accelerated glomerulopathy, and tissue fibrosis in diabetic patients. The signaling cascades potentiated in diabetic patients are indicated by red arrows</p></div></div></div><p>Several lines of evidence suggest that IGFBP&#x02010;3 acts as a potential tumor suppressor gene. First, aberrant promoter methylation of IGFBP&#x02010;3 gene, which silences its expression, is detected in human gastric cancer, colorectal cancer, breast cancer, and malignant mesothelioma cancer.<sup><a href="#fba21236-bib-0020" rid="fba21236-bib-0020" class=" bibr popnode">20</a></sup> Second, low levels of IGFBP&#x02010;3 expression in cancer tissues are correlated with poor prognosis for patients with esophageal squamous cell carcinoma<sup><a href="#fba21236-bib-0043" rid="fba21236-bib-0043" class=" bibr popnode">43</a></sup> and hepatocellular carcinoma.<sup><a href="#fba21236-bib-0044" rid="fba21236-bib-0044" class=" bibr popnode">44</a></sup> Third, low IGFBP&#x02010;3 expression correlates clinically with higher tumor grade, advanced stage, and poor survival in ovarian endometrioid adenocarcinoma patients.<sup><a href="#fba21236-bib-0045" rid="fba21236-bib-0045" class=" bibr popnode">45</a></sup> Here, we demonstrate that IGFBP&#x02010;3 inhibits cell growth by stimulating the T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling pathway (T&#x003b2;R&#x02010;V/IRS&#x02010;1/2/PP2A/p130, p107). Among the components of this signaling cascade, T&#x003b2;R&#x02010;V and PP2A have been proved to be tumor suppressor genes by that stable transfection of human carcinoma cells and CHO&#x02010;LRP&#x02010;1<sup>&#x02212;/&#x02212;</sup> cells with LRP&#x02010;1 (T&#x003b2;R&#x02010;V) cDNA restores the growth inhibitory response to IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;, and normal epithelial morphology<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0015" rid="fba21236-bib-0015" class=" bibr popnode">15</a></sup> and by that loss of PP2A regulatory subunit B56&#x003b4; promotes spontaneous tumorigenesis in vivo.<sup><a href="#fba21236-bib-0046" rid="fba21236-bib-0046" class=" bibr popnode">46</a></sup> In addition, knockout of the T&#x003b2;R&#x02010;V (LRP&#x02010;1) gene and both p130 and p107 genes in mice has been shown to cause embryonic and neonatal lethality, respectively.<sup><a href="#fba21236-bib-0047" rid="fba21236-bib-0047" class=" bibr popnode">47</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0048" rid="fba21236-bib-0048" class=" bibr popnode">48</a></sup> In normal epithelial cells, IGFBP&#x02010;3 induces growth inhibition by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated and IRS&#x02010;1/2&#x02010;dependent activation of PP2A. PP2A may serve as an important down&#x02010;stream effector for mediating other known cell biological activities of IGFBP&#x02010;3 and other high&#x02010;affinity IGFBPs.<sup><a href="#fba21236-bib-0001" rid="fba21236-bib-0001" class=" bibr popnode">1</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0036" rid="fba21236-bib-0036" class=" bibr popnode">36</a></sup>
</p><p>T&#x003b2;R&#x02010;V is the only cell surface IGFBP&#x02010;3 receptor identified by I<sup>125</sup>&#x02010;labeled IGFBP&#x02010;3 affinity labeling (binding/cross&#x02010;linking) followed by immunoprecipitation using antiserum to T&#x003b2;R&#x02010;V in epithelial cells and other cell types.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0006" rid="fba21236-bib-0006" class=" bibr popnode">6</a></sup> T&#x003b2;R&#x02010;V also binds IGFBP&#x02010;4 and IGFBP&#x02010;5 but not IGFBP&#x02010;1, IGFBP&#x02010;2, and IGFBP&#x02010;6, as determined by I<sup>125</sup>&#x02010;labeled IGFBPs affinity labeling.<sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0006" rid="fba21236-bib-0006" class=" bibr popnode">6</a></sup> It exhibits the highest binding affinity toward IGFBP&#x02010;3 with a K<sub>d</sub> of 10&#x000a0;nM.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0006" rid="fba21236-bib-0006" class=" bibr popnode">6</a></sup> A TGF&#x02010;&#x003b2; peptide antagonist &#x003b2;<sub>1</sub>
<sup>25</sup>, which contains a minimal active site motif of WS/CXD in TGF&#x02010;&#x003b2; and IGFBP&#x02010;3 molecules, blocks TGF&#x02010;&#x003b2; and IGFBP&#x02010;3 binding to TGF&#x02010;&#x003b2; receptors in epithelial cells and reverses growth inhibition induced by either TGF&#x02010;&#x003b2; or IGFBP&#x02010;3 in these cells.<sup><a href="#fba21236-bib-0004" rid="fba21236-bib-0004" class=" bibr popnode">4</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0005" rid="fba21236-bib-0005" class=" bibr popnode">5</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0011" rid="fba21236-bib-0011" class=" bibr popnode">11</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0012" rid="fba21236-bib-0012" class=" bibr popnode">12</a></sup> The transmembrane protein TMEM219 (25&#x000a0;kDa) was also identified as an IGFBP&#x02010;3 receptor (termed IGFBP&#x02010;3R) in 2010, using the yeast two&#x02010;hybrid screening and a human breast cancer cell cDNA library.<sup><a href="#fba21236-bib-0049" rid="fba21236-bib-0049" class=" bibr popnode">49</a></sup> In contrast to the IGFBP&#x02010;3 receptor (T&#x003b2;R&#x02010;V/LRP&#x02010;1), IGFBP&#x02010;3R/TMEM219 does not bind other high&#x02010;affinity IGFBPs<sup><a href="#fba21236-bib-0049" rid="fba21236-bib-0049" class=" bibr popnode">49</a></sup> and have known function of a tumor suppressor gene. IGFBP&#x02010;3R/TMEM219 was identified as a cell death receptor mediating IGFBP&#x02010;3&#x02010;induced anti&#x02010;tumor effects in cancer cells<sup><a href="#fba21236-bib-0049" rid="fba21236-bib-0049" class=" bibr popnode">49</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0050" rid="fba21236-bib-0050" class=" bibr popnode">50</a></sup> and as an autophagy&#x02010;activation receptor mediating IGFBP&#x02010;3&#x02010;activated autophagy in Vero cells.<sup><a href="#fba21236-bib-0051" rid="fba21236-bib-0051" class=" bibr popnode">51</a></sup> In addition, the K<sub>d</sub> of IGFBP&#x02010;3 binding to TMEM219/IGFBP&#x02010;3R has been estimated to be 125&#x000a0;nM.<sup><a href="#fba21236-bib-0051" rid="fba21236-bib-0051" class=" bibr popnode">51</a></sup> IGFBP&#x02010;3 (1&#x000a0;&#x000b5;M) is utilized to stimulate TMEM219/IGFBP&#x02010;3R&#x02010;mediated autophagy activation in Vero cells (kidney epithelial cells).<sup><a href="#fba21236-bib-0051" rid="fba21236-bib-0051" class=" bibr popnode">51</a></sup> It is important to note that carcinoma cancer cells do not express the IGFBP&#x02010;3 receptor (T&#x003b2;R&#x02010;V) and loss of T&#x003b2;R&#x02010;V confers cancer malignancy.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> Many lines of evidence suggest that the IGFBP&#x02010;3 receptor (T&#x003b2;R&#x02010;V) is the primary IGFBP&#x02010;3 receptor in normal epithelial cells and other cell types.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup>
</p><p>The transcriptional activation and growth inhibition activities of TGF&#x02010;&#x003b2; have generally been thought to be mediated by the canonical T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling cascade.<sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> However, these two activities appear to segregate in several cell types and under various conditions.<sup><a href="#fba21236-bib-0052" rid="fba21236-bib-0052" class=" bibr popnode">52</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0053" rid="fba21236-bib-0053" class=" bibr popnode">53</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0054" rid="fba21236-bib-0054" class=" bibr popnode">54</a></sup> This suggests that other signaling pathways must be involved in mediating the TGF&#x02010;&#x003b2; activities. Although TGF&#x02010;&#x003b2;&#x02010;stimulated canonical T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling can be modulated by other signaling pathways,<sup><a href="#fba21236-bib-0055" rid="fba21236-bib-0055" class=" bibr popnode">55</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0056" rid="fba21236-bib-0056" class=" bibr popnode">56</a></sup> it is mainly responsible for mediating the transcriptional activation of ECM synthesis&#x02010;related genes. Smad2/3/4 responsive elements exist in the promoter regions of all responsive genes. In contrast, the signaling involved in TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in target cells is unknown. Other signaling pathways, in addition to the well&#x02010;known canonical T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling pathway, are suggested to be involved in the growth inhibitory response to TGF&#x02010;&#x003b2;.<sup><a href="#fba21236-bib-0057" rid="fba21236-bib-0057" class=" bibr popnode">57</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0058" rid="fba21236-bib-0058" class=" bibr popnode">58</a></sup> The Ras/ERK signaling and PP2A are involved in mediating TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in certain cells.<sup><a href="#fba21236-bib-0059" rid="fba21236-bib-0059" class=" bibr popnode">59</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0060" rid="fba21236-bib-0060" class=" bibr popnode">60</a></sup> However, the main signaling pathway, in concert with canonical T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling,<sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> mediates the growth inhibitory response to TGF&#x02010;&#x003b2; in epithelial cells remains unknown. T&#x003b2;R&#x02010;I, T&#x003b2;R&#x02010;II, T&#x003b2;R&#x02010;III, and T&#x003b2;R&#x02010;V co&#x02010;express in all normal cell types studied. Since the T&#x003b2;R&#x02010;III null mutation in mice does not affect the growth regulatory response to TGF&#x02010;&#x003b2; in embryonic fibroblasts derived from these mice,<sup><a href="#fba21236-bib-0061" rid="fba21236-bib-0061" class=" bibr popnode">61</a></sup> the remaining candidate is T&#x003b2;R&#x02010;V. Many carcinoma cells and primary tumors express no or very low levels of T&#x003b2;R&#x02010;V expression.<sup><a href="#fba21236-bib-0002" rid="fba21236-bib-0002" class=" bibr popnode">2</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0016" rid="fba21236-bib-0016" class=" bibr popnode">16</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0017" rid="fba21236-bib-0017" class=" bibr popnode">17</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0018" rid="fba21236-bib-0018" class=" bibr popnode">18</a></sup> Growth of these cells is not inhibited by either TGF&#x02010;&#x003b2; or IGFBP&#x02010;3. In the absence of T&#x003b2;R&#x02010;V in late&#x02010;stage cancer, TGF&#x02010;&#x003b2; induces EMT (epithelial&#x02013;mesenchymal transition), autoinduction, and increased invasiveness by stimulating T&#x003b2;R&#x02010;I&#x02010;activated or T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad signaling pathways<sup><a href="#fba21236-bib-0037" rid="fba21236-bib-0037" class=" bibr popnode">37</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0038" rid="fba21236-bib-0038" class=" bibr popnode">38</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0039" rid="fba21236-bib-0039" class=" bibr popnode">39</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0040" rid="fba21236-bib-0040" class=" bibr popnode">40</a></sup> as well as canonical Smad signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4 signaling).<sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> T&#x003b2;R&#x02010;II is apparently not involved in TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;I&#x02010;activated/mediated non&#x02010;Smad signaling pathways<sup><a href="#fba21236-bib-0037" rid="fba21236-bib-0037" class=" bibr popnode">37</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0038" rid="fba21236-bib-0038" class=" bibr popnode">38</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0039" rid="fba21236-bib-0039" class=" bibr popnode">39</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0040" rid="fba21236-bib-0040" class=" bibr popnode">40</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0041" rid="fba21236-bib-0041" class=" bibr popnode">41</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0042" rid="fba21236-bib-0042" class=" bibr popnode">42</a></sup> which are involved in cell survival, migration, proliferation, malignant transformation, and tumor growth. In fact, TGF&#x02010;&#x003b2; stimulates tumor promoter signaling toward EMT is mediated by both non&#x02010;Smad and Smad pathways. While no LRP&#x02010;1 (T&#x003b2;R&#x02010;V) is detected in hepatoma in human patients, it is present in the normal parenchymal tissue surrounding the hepatomas.<sup><a href="#fba21236-bib-0016" rid="fba21236-bib-0016" class=" bibr popnode">16</a></sup> These suggest that T&#x003b2;R&#x02010;V is involved in mediating the growth inhibitory response to TGF&#x02010;&#x003b2; in normal epithelial cells and that its loss contributes to the malignant phenotype in cancer cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> These are also consistent with the notion that T&#x003b2;R&#x02010;V acts as a tumor suppressor gene and controls cell growth in normal epithelial cells by mediating TGF&#x02010;&#x003b2;&#x02010;induced growth inhibition in these cells. The loss or deficiency of T&#x003b2;R&#x02010;V leads to the development of carcinoma cancer. Although no mutation in the LRP&#x02010;1 (T&#x003b2;R&#x02010;V) gene has been found related to cancer initiation or progression, the T allele of the C766&#x000a0;T polymorphism in the LRP&#x02010;1 (T&#x003b2;R&#x02010;V) gene is associated with an increased risk of breast cancer.<sup><a href="#fba21236-bib-0062" rid="fba21236-bib-0062" class=" bibr popnode">62</a></sup>
</p><p>We previously proposed a model for the mechanism by which TGF&#x02010;&#x003b2; inhibits growth in epithelial cells by binding to a site between cell surface subdomains I and II of T&#x003b2;R&#x02010;V in target cells. In this model, TGF&#x02010;&#x003b2; stimulates sequential association of IRS&#x02010;1 or IRS&#x02010;2 and a Ser/Thr&#x02010;specific PPase with the cytoplasmic tail of T&#x003b2;R&#x02010;V by inducing T&#x003b2;R&#x02010;V dimerization via its covalently linked homodimeric structure. In the ternary complexes, the Ser/Thr&#x02010;specific PPase becomes activated and dephosphorylate IRS&#x02010;1/2. Dephosphorylated IRS&#x02010;1&#x02010;PPase or IRS&#x02010;2&#x02010;PPase binary complexes dissociate from the cytoplasmic tail of T&#x003b2;R&#x02010;V and undergo IRS&#x02010;1/2&#x02010;dependent translocation from cytoplasm to the nucleus where the PPase dephosphorylates pRb (retinoblastoma protein) or pRb&#x02010;related proteins, resulting in growth arrest. This model lacked the identity of PPase, IRS&#x02010;1/2, and retinoblastoma family proteins which are involved in TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor (growth inhibition) signaling.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> Here, we provide several lines of evidence to suggest that PP1, IRS&#x02010;1/2, and pRb (p105) are involved in the TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb). These include: (1) TGF&#x02010;&#x003b2; stimulates colocalization of T&#x003b2;R&#x02010;V and IRS&#x02010;1/2 at the plasma membrane in Mv1Lu cells, as demonstrated by immunofluorescence staining. (2) TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of IRS&#x02010;2 but not IRS&#x02010;1 in Mv1Lu cells, as demonstrated by immunofluorescence staining. (3) PP1 is known to be responsible for mediating TGF&#x02010;&#x003b2;&#x02010;stimulated dephosphorylation of pRb in keratinocytes and Mv1Lu cells.<sup><a href="#fba21236-bib-0028" rid="fba21236-bib-0028" class=" bibr popnode">28</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0029" rid="fba21236-bib-0029" class=" bibr popnode">29</a></sup> (4) TGF&#x02010;&#x003b2;&#x02010;stimulated PPase (PP1) activity is abolished in cells co&#x02010;treated with RAP (LRP&#x02010;1/T&#x003b2;R&#x02010;V antagonist) or insulin<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0022" rid="fba21236-bib-0022" class=" bibr popnode">22</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0023" rid="fba21236-bib-0023" class=" bibr popnode">23</a></sup> in Mv1Lu cells. (5) TGF&#x02010;&#x003b2;&#x02010;stimulated PPase (PP1) activity is distinct from IGFBP&#x02010;3&#x02010;stimulated PPase (PP2A) activity in its relative insensitivity to OA inhibition, which appears to be the biochemical character of PP1 activity.<sup><a href="#fba21236-bib-0026" rid="fba21236-bib-0026" class=" bibr popnode">26</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> PP2A is completely inhibited at 1&#x000a0;nM OA, compared to greater than 1&#x000a0;&#x000b5;M OA for PP1.<sup><a href="#fba21236-bib-0026" rid="fba21236-bib-0026" class=" bibr popnode">26</a></sup> (6) OA at 0.5&#x000a0;nM completely inhibits IGFBP&#x02010;3&#x02010;stimulated PPase (PP2A) activity, but not TGF&#x02010;&#x003b2;&#x02010;stimulated PPase (PP1) activity, in Mv1Lu cells treated with IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;. (7) TGF&#x02010;&#x003b2; stimulates cytoplasm&#x02010;to&#x02010;nucleus translocation of PP1<sub>c</sub>, resulting in dephosphorylation of pRb (p105) in the nucleus, as demonstrated by Western blot analysis following subcellular fractionation (to yield cytoplasm and nucleus fractions) and immunofluorescence analysis. (8) PP1 as well as PP2A are the master regulators of the eukaryotic cell cycle.<sup><a href="#fba21236-bib-0027" rid="fba21236-bib-0027" class=" bibr popnode">27</a></sup> The above evidence supports an updated model (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><span>8B</span></a>) in which TGF&#x02010;&#x003b2; induces growth inhibition in target cells by stimulating T&#x003b2;R&#x02010;V&#x02010;mediated signaling (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1) which leads to dephosphorylation of pRb (p105) in the nucleus, resulting in cell growth arrest.</p><p>In this model (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><span>8B</span></a>), TGF&#x02010;&#x003b2;, a covalently associated homodimeric cytokine, interacts with T&#x003b2;R&#x02010;V at a site between subdomains I and II,<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> resulting in dimerization of T&#x003b2;R&#x02010;V and sequential recruitment of IRS&#x02010;1 or IRS&#x02010;2 and PP1 to the cytoplasmic tail of dimeric T&#x003b2;R&#x02010;V to form T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;1&#x02010;PP1 or T&#x003b2;R&#x02010;V&#x02010;IRS&#x02010;2&#x02010;PP1 ternary complexes. IRS&#x02010;1 and IRS&#x02010;2 possess PP1<sub>c</sub> docking motifs of FrssfR (residues 438&#x02013;443) and FefRpR (residues 298&#x02013;303), respectively (PP1<sub>c</sub> docking affinity: IRS&#x02010;2&#x000a0;&#x0003e;&#x000a0;IRS&#x02010;1). IRS&#x02010;2 appears to comprise of overlapping high&#x02010;affinity PP1 and PP2A docking motifs of FefRpR (residues 298&#x02013;303) and LkeLfE (residues 294&#x02013;299), respectively, suggesting that PP1 and PP2A docking to IRS&#x02010;2 are mutually exclusive. After dephosphorylation of IRS&#x02010;2 by activated PP1 in the ternary complex, dephosphorylated IRS&#x02010;2&#x02010;PP1 binary complexes dissociate from the cytoplasmic tail of T&#x003b2;R&#x02010;V and enter the nucleus via the nucleus&#x02010;targeting function of IRS&#x02010;2. In the nucleus, PP1 dephosphorylates pRb (p105), resulting in cell growth arrest. In normal epithelial cells, TGF&#x02010;&#x003b2; potently inhibits cell growth (~100% growth inhibition at 1&#x02013;5&#x000a0;pM) by stimulating the T&#x003b2;R&#x02010;V&#x02010;mediated signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) to dephosphorylate (activate) pRb by PP1 in concert with canonical TGF&#x02010;&#x003b2; signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4).<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> TGF&#x02010;&#x003b2;&#x02010;stimulated canonical signaling potentiates T&#x003b2;R&#x02010;V&#x02010;mediated growth inhibition in these epithelial cells, at least in part, by transcriptional activation of cyclin&#x02010;dependent kinase (CDK) inhibitors which maintain pRb unphosphorylated (active) in the nucleus.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> Moreover, upon TGF&#x02010;&#x003b2; stimulation in cells, dephosphorylated IRS&#x02010;1&#x02010;PP1 complexes also dissociate from T&#x003b2;R&#x02010;V and bind (or anchor) to a high&#x02010;affinity PP1 docking motif FesfKR (residues 393&#x02013;398) in the cytoplasmic domain of T&#x003b2;R&#x02010;I in the T&#x003b2;R&#x02010;V&#x02013;T&#x003b2;R&#x02010;I complex.<sup><a href="#fba21236-bib-0009" rid="fba21236-bib-0009" class=" bibr popnode">9</a></sup> Since PP1<sub>c</sub> itself possesses a high&#x02010;affinity PP2A&#x02010;B56 docking motif of LlrLfE (residues 82&#x02013;87), on the way to bind to T&#x003b2;R&#x02010;I (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><span>8B</span></a>), PP1<sub>c</sub> also recruits PP2A to form the high&#x02010;affinity&#x02010;bound T&#x003b2;R&#x02010;1&#x02010;PP<sub>c</sub>&#x02010;PP2A complex. PP2A recruited by T&#x003b2;R&#x02010;1 as the high&#x02010;affinity&#x02010;bound PP1&#x02010;PP2A complex<sup><a href="#fba21236-bib-0063" rid="fba21236-bib-0063" class=" bibr popnode">63</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0064" rid="fba21236-bib-0064" class=" bibr popnode">64</a></sup> effectively suppresses or silences TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad pathways by dephosphorylation of the kinases involved in non&#x02010;Smad pathways in normal epithelial cells. However, in cancer cells lacking T&#x003b2;R&#x02010;V expression,<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup> T&#x003b2;R&#x02010;I is transiently localized in lipid rafts due to its specific interaction with caveolin&#x02010;1, a structural component of lipid rafts.<sup><a href="#fba21236-bib-0065" rid="fba21236-bib-0065" class=" bibr popnode">65</a></sup> Lipid rafts serve as major platforms for non&#x02010;Smad signaling regulation in cell migration and proliferation.<sup><a href="#fba21236-bib-0066" rid="fba21236-bib-0066" class=" bibr popnode">66</a></sup> In these cancer cells, T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad signaling pathways are activated by TGF&#x02010;&#x003b2; due to defective recruitment of PP&#x02010;1<sub>c</sub>&#x02010;PP2A by T&#x003b2;R&#x02010;I to suppress non&#x02010;Smad signaling.<sup><a href="#fba21236-bib-0042" rid="fba21236-bib-0042" class=" bibr popnode">42</a></sup> Furthermore, in carcinoma cells, loss or very low levels of T&#x003b2;R&#x02010;V expression do not affect TGF&#x02010;&#x003b2;&#x02010;stimulated canonical signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad&#x02010;2/3/4), as evidenced by TGF&#x02010;&#x003b2;&#x02010;stimulated expression of PAI&#x02010;1 in these cells.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> Thus, as a tumor promoter, TGF&#x02010;&#x003b2; stimulates both Smad and non&#x02010;Smad signaling (termed tumor promoter signaling), leading to epithelial mesenchymal transition (EMT), autoinduction, invasiveness, and chemoresistance in these cancer cells. PP2A plays a pivotal role in suppressing the development of cancer malignancy via TGF&#x02010;&#x003b2;&#x02010;induced T&#x003b2;R&#x02010;I recruitment of PP1&#x02010;PP2A complexes<sup><a href="#fba21236-bib-0041" rid="fba21236-bib-0041" class=" bibr popnode">41</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0042" rid="fba21236-bib-0042" class=" bibr popnode">42</a></sup> to suppress non&#x02010;Smad signaling pathways.<sup><a href="#fba21236-bib-0037" rid="fba21236-bib-0037" class=" bibr popnode">37</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0038" rid="fba21236-bib-0038" class=" bibr popnode">38</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0039" rid="fba21236-bib-0039" class=" bibr popnode">39</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0040" rid="fba21236-bib-0040" class=" bibr popnode">40</a></sup> The expression and activity of PP2A are commonly reduced in cancer tissues. Small molecule PP2A activators have been developed to treat cancer.<sup><a href="#fba21236-bib-0067" rid="fba21236-bib-0067" class=" bibr popnode">67</a></sup>
</p><p>TGF&#x02010;&#x003b2; is known to act as a tumor suppressor and a tumor promoter during tumorigenesis. The mechanism of switching TGF&#x02010;&#x003b2; from a tumor suppressor to a tumor promoter in the process of tumorigenesis remains unclear.<sup><a href="#fba21236-bib-0068" rid="fba21236-bib-0068" class=" bibr popnode">68</a></sup> We hypothesize that the presence and absence of T&#x003b2;R&#x02010;V expression in target cells appear to be critical in determining whether TGF&#x02010;&#x003b2; is a tumor suppressor or a tumor promoter.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup> In normal epithelial cells which express T&#x003b2;R&#x02010;V, TGF&#x02010;&#x003b2; suppresses carcinogenesis by potently inhibiting cell growth via stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;2&#x02010;dependent tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) in concert with T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical TGF&#x02010;&#x003b2; signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4) and by suppressing tumor progression via stimulating T&#x003b2;R&#x02010;V&#x02010;mediated IRS&#x02010;1&#x02010;dependent activation and formation of PP1&#x02010;PP2A complexes (T&#x003b2;R&#x02010;V/IRS&#x02010;1/PP1&#x02010;PP2A) which targets and suppresses T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad tumor progression signaling (Figure&#x000a0;<a href="/pmc/articles/PMC8409558/figure/fba21236-fig-0008/" target="figure" class="fig-table-link figpopup" rid-figpopup="fba21236-fig-0008" rid-ob="ob-fba21236-fig-0008" co-legend-rid="lgnd_fba21236-fig-0008"><span>8B</span></a>). In cancer cells, loss or very low levels of T&#x003b2;R&#x02010;V expression cause the inability of TGF&#x02010;&#x003b2; to inhibit cell growth but promote tumor growth. In the absence of T&#x003b2;R&#x02010;V and PP1&#x02010;PP2A complexes in cancer cells, T&#x003b2;R&#x02010;I becomes active as a homodimeric protein. In these cells, TGF&#x02010;&#x003b2; is able to stimulate T&#x003b2;R&#x02010;I&#x02010;mediated non&#x02010;Smad signaling pathways. Together with canonical Smad signaling,<sup><a href="#fba21236-bib-0013" rid="fba21236-bib-0013" class=" bibr popnode">13</a></sup> non&#x02010;Smad signaling contributes to TGF&#x02010;&#x003b2;&#x02010;induced EMT, autoinduction, invasiveness, chemoresistance, and immunomodulation in late&#x02010;stage cancer. This raises an interesting question: how much minimum expression threshold of T&#x003b2;R&#x02010;V in epithelial cells is required for switching TGF&#x02010;&#x003b2; from a tumor suppressor to a tumor promoter. To test this, we used pseudomonas exotoxin treatment of Mv1Lu cells to select mutant cells with reduced expression of T&#x003b2;R&#x02010;V (LRP&#x02010;1).<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> We found that PEA&#x02010;C11 cells, a representative clone, possess ~15% as much cell surface T&#x003b2;R&#x02010;V as parent cells and that TGF&#x02010;&#x003b2;, at 40&#x000a0;pM, inhibits cell growth in PEA&#x02010;C11 cells by 70% as compared with ~100% inhibition in wild&#x02010;type Mv1Lu cells.<sup><a href="#fba21236-bib-0010" rid="fba21236-bib-0010" class=" bibr popnode">10</a></sup> These results suggest that relatively low levels of T&#x003b2;R&#x02010;V at the cell surface are enough to maintain the status of TGF&#x02010;&#x003b2; as a growth inhibitor or T&#x003b2;R&#x02010;V as a tumor suppressor in target cells. They also suggest that T&#x003b2;R&#x02010;V (LRP&#x02010;1)&#x02010;knockdown approach (e.g., siRNA) may not be perfect for examining the role of T&#x003b2;R&#x02010;V in the cellular function of interest because of possibly enough presence of remaining T&#x003b2;R&#x02010;V (~15%) in LRP&#x02010;1 knockdown cells.<sup><a href="#fba21236-bib-0070" rid="fba21236-bib-0070" class=" bibr popnode">70</a></sup>
</p><p class="p p-last">Activation of tumor suppressors or their signaling for the treatment of human cancers has been a long sought, yet elusive, strategy for an effective therapy.<sup><a href="#fba21236-bib-0071" rid="fba21236-bib-0071" class=" bibr popnode">71</a></sup> T&#x003b2;R&#x02010;V is the only known membrane receptor which acts as a tumor suppressor required for epithelial cells.<sup><a href="#fba21236-bib-0007" rid="fba21236-bib-0007" class=" bibr popnode">7</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup> More than 80% of human cancers are carcinomas. The T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling cascade should be an ideal target for developing a strategy to prevent and treat carcinoma cancer. As described above, TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical signaling is responsible for potentiating TGF&#x02010;&#x003b2; growth inhibition mediated by T&#x003b2;R&#x02010;V by transcriptional activation of CDK inhibitors which activates the T&#x003b2;R&#x02010;V&#x02010;mediated tumor suppressor signaling cascade (T&#x003b2;R&#x02010;V/IRS&#x02010;2/PP1/pRb) to maintain pRb unphosphorylated (active). Small molecule TGF&#x02010;&#x003b2; enhancers (statins, vitamin D2, vitamin D3, cyanidin, apocyanin, dynasore, resveratrol, aspirin, ethanol, and DMSO), which enhance TGF&#x02010;&#x003b2; activity in epithelial cells, have been identified using a TGF&#x02010;&#x003b2;&#x02010;stimulated luciferase reporter gene assay in MLE cells&#x02010;Clone 32.<sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0072" rid="fba21236-bib-0072" class=" bibr popnode">72</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0073" rid="fba21236-bib-0073" class=" bibr popnode">73</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0074" rid="fba21236-bib-0074" class=" bibr popnode">74</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0075" rid="fba21236-bib-0075" class=" bibr popnode">75</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0076" rid="fba21236-bib-0076" class=" bibr popnode">76</a></sup> These small molecule enhancers enhance TGF&#x02010;&#x003b2;&#x02010;stimulated T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II&#x02010;mediated canonical signaling (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/Smad2/3/4) by recruiting T&#x003b2;R&#x02010;I&#x02013;T&#x003b2;R&#x02010;II hetero&#x02010;oligomeric complexes from lipid rafts to non&#x02010;lipid raft microdomains<sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0072" rid="fba21236-bib-0072" class=" bibr popnode">72</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0073" rid="fba21236-bib-0073" class=" bibr popnode">73</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0075" rid="fba21236-bib-0075" class=" bibr popnode">75</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0076" rid="fba21236-bib-0076" class=" bibr popnode">76</a></sup> and facilitating TGF&#x02010;&#x003b2;&#x02010;induced signaling at coated&#x02010;pit stages during clathrin&#x02010;mediated endocytosis.<sup><a href="#fba21236-bib-0074" rid="fba21236-bib-0074" class=" bibr popnode">74</a></sup> In epithelial cells, T&#x003b2;R&#x02010;V is mainly localized in plasma&#x02010;membrane non&#x02010;lipid raft microdomains which serve as signaling platforms for TGF&#x02010;&#x003b2; receptor (T&#x003b2;R&#x02010;I/T&#x003b2;R&#x02010;II/T&#x003b2;R&#x02010;V)&#x02010;mediated growth inhibition signaling. These TGF&#x02010;&#x003b2; enhancers could be used to prevent and treat the majority (carcinoma) of human cancers,<sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup> and other chronic inflammatory diseases such as atherosclerotic cardiovascular disease (ASCVD).<sup><a href="#fba21236-bib-0077" rid="fba21236-bib-0077" class=" bibr popnode">77</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0078" rid="fba21236-bib-0078" class=" bibr popnode">78</a></sup> Diets containing natural TGF&#x02010;&#x003b2; enhancers (fruits/vegetables/nuts rich in triterpenoids, polyphenols and antioxidants), synthetic TGF&#x02010;&#x003b2; enhancers (such as statins, resveratrol, cyanidin and aspirin), moderate ingestion of red wine, and exercise (which increases plasma HDL levels) are known to be associated with low risk of developing chronic inflammatory diseases such as cancer and ASCVD.<sup><a href="#fba21236-bib-0069" rid="fba21236-bib-0069" class=" bibr popnode">69</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0073" rid="fba21236-bib-0073" class=" bibr popnode">73</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0077" rid="fba21236-bib-0077" class=" bibr popnode">77</a></sup> HDL (high&#x02010;density lipoproteins), and ethanol enhance TGF&#x02010;&#x003b2; activity by recruiting T&#x003b2;R&#x02010;I and T&#x003b2;R&#x02010;II from cytoplasmic vesicles (intracellular pool) and lipid rafts/caveolae to non&#x02010;lipid raft microdomains.<sup><a href="#fba21236-bib-0073" rid="fba21236-bib-0073" class=" bibr popnode">73</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0075" rid="fba21236-bib-0075" class=" bibr popnode">75</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0078" rid="fba21236-bib-0078" class=" bibr popnode">78</a></sup> TGF&#x02010;&#x003b2; has been known to be a protective cytokine against carcinoma and ASCVD.<sup><a href="#fba21236-bib-0019" rid="fba21236-bib-0019" class=" bibr popnode">19</a></sup><sup>, </sup><sup><a href="#fba21236-bib-0079" rid="fba21236-bib-0079" class=" bibr popnode">79</a></sup>
</p></div><div id="fba21236-sec-0024" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0024title">CONFLICT OF INTEREST</h2><p class="p p-first-last">The authors declare that there are no competing financial interest associated with this work.</p></div><div id="fba21236-sec-0025" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0025title">AUTHORS' CONTRIBUTIONS</h2><p class="p p-first-last">C.L.C. performed most of the experiments in the Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine. F.W.H. was involved in identifying the negative regulation of non&#x02010;Smad pathways by T&#x003b2;R&#x02010;V. S.S.H and J.S.H. were involved in research designing and finalizing the manuscript.</p></div><div id="fba21236-sec-0023" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-sec-0023title">ACKNOWLEDGMENTS</h2><div class="sec"><p>This work was supported by U.S.P.H.S. (National Institutes of Health) grants CA38808 (J.S.H.) and AR052578 (S.S.H.). The authors are grateful to Dr. Dudley K. Strickland (Department of Vascular Biology, American Red Cross, Rockville, MD) and Dr. Martin G. Myers, Jr. (Joslin Diabetes Center, Harvard University, Boston) for providing us with RAP and 32D cells (murine 32D myeloid cells stably expressing human IR and IRS&#x02010;2), respectively. This paper is dedicated to the centennial celebration of the Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, which was founded by Nobel Laureate Edward A. Doisy in 1924.</p></div></div><div id="fba21236-bibl-0001" class="tsec sec"><h2 class="head no_bottom_margin" id="fba21236-bibl-0001title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0001">1. <span class="mixed-citation" id="fba21236-cit-0001">Baxter RC. <span class="ref-title">IGF binding proteins in cancer: mechanistic and clinical insights</span>. <span class="ref-journal">Nat Rev Cancer</span>. 2014;<span class="ref-vol">14</span>:329&#x02010;341. [<a href="https://pubmed.ncbi.nlm.nih.gov/24722429" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=IGF+binding+proteins+in+cancer:+mechanistic+and+clinical+insights&amp;volume=14&amp;publication_year=2014&amp;pages=329-341&amp;pmid=24722429&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0002">2. <span class="mixed-citation" id="fba21236-cit-0002">O'Grady P, Huang SS, Huang JS. <span class="ref-title">Expression of a new type high molecular weight receptor (type V receptor) of transforming growth factor &#x003b2; in normal and transformed cells</span>. <span class="ref-journal">Biochem Biophys Res Commun</span>. 1991;<span class="ref-vol">179</span>:378&#x02010;385. [<a href="https://pubmed.ncbi.nlm.nih.gov/1652955" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Expression+of+a+new+type+high+molecular+weight+receptor+(type+V+receptor)+of+transforming+growth+factor+&#x003b2;+in+normal+and+transformed+cells&amp;volume=179&amp;publication_year=1991&amp;pages=378-385&amp;pmid=1652955&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0003">3. <span class="mixed-citation" id="fba21236-cit-0003">O'Grady P, Kuo MD, Baldassare JJ, Huang SS, Huang JS. <span class="ref-title">Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor &#x003b2; (TGF&#x02010;&#x003b2;) from bovine liver. Identification of the type V TGF&#x02010;&#x003b2; receptor in cultured cells</span>. <span class="ref-journal">J Biol Chem</span>. 1991;<span class="ref-vol">266</span>:8583&#x02010;8589. [<a href="https://pubmed.ncbi.nlm.nih.gov/1850748" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Purification+of+a+new+type+high+molecular+weight+receptor+(type+V+receptor)+of+transforming+growth+factor+&#x003b2;+(TGF&#x02010;&#x003b2;)+from+bovine+liver.+Identification+of+the+type+V+TGF&#x02010;&#x003b2;+receptor+in+cultured+cells&amp;volume=266&amp;publication_year=1991&amp;pages=8583-8589&amp;pmid=1850748&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0004">4. <span class="mixed-citation" id="fba21236-cit-0004">Leal SM, Liu Q, Huang SS, Huang JS. <span class="ref-title">The type V transforming growth factor &#x003b2; receptor is the putative insulin&#x02010;like growth factor&#x02010;binding protein 3 receptor</span>. <span class="ref-journal">J Biol Chem</span>. 1997;<span class="ref-vol">272</span>:20572&#x02010;20576. [<a href="https://pubmed.ncbi.nlm.nih.gov/9252371" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=The+type+V+transforming+growth+factor+&#x003b2;+receptor+is+the+putative+insulin&#x02010;like+growth+factor&#x02010;binding+protein+3+receptor&amp;volume=272&amp;publication_year=1997&amp;pages=20572-20576&amp;pmid=9252371&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0005">5. <span class="mixed-citation" id="fba21236-cit-0005">Leal SM, Huang SS, Huang JS. <span class="ref-title">Interactions of high affinity insulin&#x02010;like growth factor&#x02010;binding proteins with the type V transforming growth factor&#x02010;&#x003b2; receptor in mink lung epithelial cells</span>. <span class="ref-journal">J Biol Chem</span>. 1999;<span class="ref-vol">274</span>:6711&#x02010;6717. [<a href="https://pubmed.ncbi.nlm.nih.gov/10037769" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Interactions+of+high+affinity+insulin&#x02010;like+growth+factor&#x02010;binding+proteins+with+the+type+V+transforming+growth+factor&#x02010;&#x003b2;+receptor+in+mink+lung+epithelial+cells&amp;volume=274&amp;publication_year=1999&amp;pages=6711-6717&amp;pmid=10037769&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0006">6. <span class="mixed-citation" id="fba21236-cit-0006">Leal SM. <span class="ref-title">Characterization of the interactions of IGFBP&#x02010;3 with the type V TGF&#x02010;&#x003b2; receptor</span>. Ph.D. dissertation, 1999; Saint Louis University, St. Louis, Missouri, USA.</span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0007">7. <span class="mixed-citation" id="fba21236-cit-0007">Huang SS, Huang JS. <span class="ref-title">TGF&#x02010;&#x003b2; control of cell proliferation (Review)</span>. <span class="ref-journal">J Cell Biochem</span>. 2005;<span class="ref-vol">96</span>:447&#x02010;462. [<a href="https://pubmed.ncbi.nlm.nih.gov/16088940" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem&amp;title=TGF&#x02010;&#x003b2;+control+of+cell+proliferation+(Review)&amp;volume=96&amp;publication_year=2005&amp;pages=447-462&amp;pmid=16088940&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0008">8. <span class="mixed-citation" id="fba21236-cit-0008">Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK. <span class="ref-title">Surface location and high affinity for calcium of a 500&#x02010;kd liver membrane protein closely related to the LDL&#x02010;receptor suggest a physiological role as lipoprotein receptor</span>. <span class="ref-journal">EMBO J</span>. 1988;<span class="ref-vol">7</span>:4119&#x02010;4127. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC455121/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/3266596" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J&amp;title=Surface+location+and+high+affinity+for+calcium+of+a+500&#x02010;kd+liver+membrane+protein+closely+related+to+the+LDL&#x02010;receptor+suggest+a+physiological+role+as+lipoprotein+receptor&amp;volume=7&amp;publication_year=1988&amp;pages=4119-4127&amp;pmid=3266596&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0009">9. <span class="mixed-citation" id="fba21236-cit-0009">Liu Q, Huang SS, Huang JS. <span class="ref-title">Function of the type V transforming growth factor &#x003b2; receptor in transforming growth factor &#x003b2;&#x02010;induced growth inhibition of mink lung epithelial cells</span>. <span class="ref-journal">J Biol Chem</span>. 1997;<span class="ref-vol">272</span>:18891&#x02010;18895. [<a href="https://pubmed.ncbi.nlm.nih.gov/9228067" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Function+of+the+type+V+transforming+growth+factor+&#x003b2;+receptor+in+transforming+growth+factor+&#x003b2;&#x02010;induced+growth+inhibition+of+mink+lung+epithelial+cells&amp;volume=272&amp;publication_year=1997&amp;pages=18891-18895&amp;pmid=9228067&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0010">10. <span class="mixed-citation" id="fba21236-cit-0010">Huang SS, Ling TY, Tseng WF, et al. <span class="ref-title">Cellular growth inhibition by IGFBP&#x02010;3 and TGF&#x02010;&#x003b2;1 requires LRP&#x02010;1</span>. <span class="ref-journal">FASEB J</span>. 2003;<span class="ref-vol">17</span>:2068&#x02010;2089. [<a href="https://pubmed.ncbi.nlm.nih.gov/14597676" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=Cellular+growth+inhibition+by+IGFBP&#x02010;3+and+TGF&#x02010;&#x003b2;1+requires+LRP&#x02010;1&amp;volume=17&amp;publication_year=2003&amp;pages=2068-2089&amp;pmid=14597676&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0011">11. <span class="mixed-citation" id="fba21236-cit-0011">Huang SS, Liu Q, Johnson FE, Konish Y, Huang JS. <span class="ref-title">Transforming growth factor&#x02010;&#x003b2; peptide antagonists and their conversion to partial agonists</span>. <span class="ref-journal">J Biol Chem</span>. 1997;<span class="ref-vol">272</span>:27155&#x02010;27159. [<a href="https://pubmed.ncbi.nlm.nih.gov/9341157" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Transforming+growth+factor&#x02010;&#x003b2;+peptide+antagonists+and+their+conversion+to+partial+agonists&amp;volume=272&amp;publication_year=1997&amp;pages=27155-27159&amp;pmid=9341157&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0012">12. <span class="mixed-citation" id="fba21236-cit-0012">Huang SS, Zhou M, Johnson FE, Hsieh H&#x02010;S, Huang JS. <span class="ref-title">An active site of transforming growth factor&#x02010;&#x003b2;<sub>1</sub> for growth inhibition and stimulation</span>. <span class="ref-journal">J. Biol. Chem</span>. 1999;<span class="ref-vol">274</span>:27754&#x02010;27758. [<a href="https://pubmed.ncbi.nlm.nih.gov/10488119" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem&amp;title=An+active+site+of+transforming+growth+factor&#x02010;&#x003b2;1+for+growth+inhibition+and+stimulation&amp;volume=274&amp;publication_year=1999&amp;pages=27754-27758&amp;pmid=10488119&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0013">13. <span class="mixed-citation" id="fba21236-cit-0013">Heldin CH, Miyazono K, ten Dijke P. <span class="ref-title">TGF&#x02010;&#x003b2; signaling from cell membrane to nucleus through SMAD proteins</span>. <span class="ref-journal">Nature</span>. 1997;<span class="ref-vol">390</span>:465&#x02010;471. [<a href="https://pubmed.ncbi.nlm.nih.gov/9393997" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=TGF&#x02010;&#x003b2;+signaling+from+cell+membrane+to+nucleus+through+SMAD+proteins&amp;volume=390&amp;publication_year=1997&amp;pages=465-471&amp;pmid=9393997&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0014">14. <span class="mixed-citation" id="fba21236-cit-0014">Reynisd&#x000f3;ttir I, Polyak K, Iavarone A, Massagu&#x000e9; J. <span class="ref-title">Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF&#x02010;&#x003b2;</span>. <span class="ref-journal">Genes Dev</span>. 1995;<span class="ref-vol">9</span>:1831&#x02010;1845. [<a href="https://pubmed.ncbi.nlm.nih.gov/7649471" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;title=Kip/Cip+and+Ink4+Cdk+inhibitors+cooperate+to+induce+cell+cycle+arrest+in+response+to+TGF&#x02010;&#x003b2;&amp;volume=9&amp;publication_year=1995&amp;pages=1831-1845&amp;pmid=7649471&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0015">15. <span class="mixed-citation" id="fba21236-cit-0015">Tseng WF, Huang SS, Huang JS. <span class="ref-title">LRP&#x02010;1/T&#x003b2;R&#x02010;V mediates TGF&#x02010;&#x003b2;1&#x02010;induced growth inhibition in CHO cells</span>. <span class="ref-journal">FEBS Lett</span>. 2004;<span class="ref-vol">562</span>:71&#x02010;78. [<a href="https://pubmed.ncbi.nlm.nih.gov/15044004" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=LRP&#x02010;1/T&#x003b2;R&#x02010;V+mediates+TGF&#x02010;&#x003b2;1&#x02010;induced+growth+inhibition+in+CHO+cells&amp;volume=562&amp;publication_year=2004&amp;pages=71-78&amp;pmid=15044004&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0016">16. <span class="mixed-citation" id="fba21236-cit-0016">Huang XY, Shi GM, Devbhandari RP, et al. <span class="ref-title">Low level of low&#x02010;density lipoprotein receptor&#x02010;related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection</span>. <span class="ref-journal">PLoS One</span>. 2012;<span class="ref-vol">7</span>:e32775. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3299691/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22427881" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Low+level+of+low&#x02010;density+lipoprotein+receptor&#x02010;related+protein+1+predicts+an+unfavorable+prognosis+of+hepatocellular+carcinoma+after+curative+resection&amp;volume=7&amp;publication_year=2012&amp;pages=e32775&amp;pmid=22427881&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0017">17. <span class="mixed-citation" id="fba21236-cit-0017">Boulagnon&#x02010;Rombi C, Schneider C, Leandri C, et al. <span class="ref-title">LRP1 expression in colon cancer predicts clinical outcome</span>. <span class="ref-journal">Oncotarget</span>. 2018;<span class="ref-vol">9</span>:8849&#x02010;8869. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5823651/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29507659" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=LRP1+expression+in+colon+cancer+predicts+clinical+outcome&amp;volume=9&amp;publication_year=2018&amp;pages=8849-8869&amp;pmid=29507659&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0018">18. <span class="mixed-citation" id="fba21236-cit-0018">Gilardoni MB, Remedi MM, Oviedo M, et al. <span class="ref-title">Differential expression of Low density lipoprotein receptor&#x02010;related Protein 1 (LRP&#x02010;1) and matrix metalloproteinase&#x02010;9 (MMP&#x02010;9) in prostate gland: from normal to malignant lesions</span>. <span class="ref-journal">Pathol Res Pract</span>. 2017;<span class="ref-vol">213</span>:66&#x02010;71. [<a href="https://pubmed.ncbi.nlm.nih.gov/27931798" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pathol+Res+Pract&amp;title=Differential+expression+of+Low+density+lipoprotein+receptor&#x02010;related+Protein+1+(LRP&#x02010;1)+and+matrix+metalloproteinase&#x02010;9+(MMP&#x02010;9)+in+prostate+gland:+from+normal+to+malignant+lesions&amp;volume=213&amp;publication_year=2017&amp;pages=66-71&amp;pmid=27931798&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0019">19. <span class="mixed-citation" id="fba21236-cit-0019">Derynck R, Akhurst RJ, Balmain A. <span class="ref-title">TGF&#x02010;&#x003b2; signaling in tumor suppression and cancer progression</span>. <span class="ref-journal">Nat Genet</span>. 2001;<span class="ref-vol">29</span>:117&#x02010;129. [<a href="https://pubmed.ncbi.nlm.nih.gov/11586292" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=TGF&#x02010;&#x003b2;+signaling+in+tumor+suppression+and+cancer+progression&amp;volume=29&amp;publication_year=2001&amp;pages=117-129&amp;pmid=11586292&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0020">20. <span class="mixed-citation" id="fba21236-cit-0020">Tomii K, Tsukuda K, Toyooka S, et al. <span class="ref-title">Aberrant promoter methylation of insulin&#x02010;like growth factor binding protein&#x02010;3 gene in human cancers</span>. <span class="ref-journal">Int J Cancer</span>. 2007;<span class="ref-vol">120</span>:566&#x02010;573. [<a href="https://pubmed.ncbi.nlm.nih.gov/17096329" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Cancer&amp;title=Aberrant+promoter+methylation+of+insulin&#x02010;like+growth+factor+binding+protein&#x02010;3+gene+in+human+cancers&amp;volume=120&amp;publication_year=2007&amp;pages=566-573&amp;pmid=17096329&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0021">21. <span class="mixed-citation" id="fba21236-cit-0021">Roberts AB, Wakefield LM. <span class="ref-title">The two faces of transforming growth factor &#x003b2; in carcinogenesis</span>. <span class="ref-journal">Proc Natl Acad Sci USA</span>. 2003;<span class="ref-vol">100</span>:8621&#x02010;8623. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC166359/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12861075" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=The+two+faces+of+transforming+growth+factor+&#x003b2;+in+carcinogenesis&amp;volume=100&amp;publication_year=2003&amp;pages=8621-8623&amp;pmid=12861075&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0022">22. <span class="mixed-citation" id="fba21236-cit-0022">Huang SS, Leal SM, Chen CL, Liu IH, Huang JS. <span class="ref-title">Identification of insulin receptor substrate proteins as key molecules for the T&#x003b2;R&#x02010;V/LRP&#x02010;1&#x02010;mediated growth inhibitory signaling cascade in epithelial and myeloid cells</span>. <span class="ref-journal">FASEB J</span>. 2004;<span class="ref-vol">18</span>:1719&#x02010;1721.FASEB J express article 10.1096/fj.04-1872fje. Published online Sept. 15, 2004a, page 1&#x02010;26. [<a href="https://pubmed.ncbi.nlm.nih.gov/15371331" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//doi.org/10.1096%2Ffj.04-1872fje" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J&amp;title=Identification+of+insulin+receptor+substrate+proteins+as+key+molecules+for+the+T&#x003b2;R&#x02010;V/LRP&#x02010;1&#x02010;mediated+growth+inhibitory+signaling+cascade+in+epithelial+and+myeloid+cells&amp;volume=18&amp;publication_year=2004&amp;pages=1719-1721&amp;pmid=15371331&amp;doi=10.1096/fj.04-1872fje&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0023">23. <span class="mixed-citation" id="fba21236-cit-0023">Huang SS, Leal SM, Chen CL, Liu IH, Huang JS. <span class="ref-title">Cellular growth inhibition by TGF&#x02010;&#x003b2;1 involves IRS proteins</span>. <span class="ref-journal">FEBS Lett</span>. 2004;<span class="ref-vol">565</span>:117&#x02010;121. [<a href="https://pubmed.ncbi.nlm.nih.gov/15135063" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=Cellular+growth+inhibition+by+TGF&#x02010;&#x003b2;1+involves+IRS+proteins&amp;volume=565&amp;publication_year=2004&amp;pages=117-121&amp;pmid=15135063&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0024">24. <span class="mixed-citation" id="fba21236-cit-0024">Fitzgerald DJ, Fryling CM, Zanovsky A, et al. <span class="ref-title">Pseudomonas exotoxin&#x02010;mediated selection yields cells with altered expression of low&#x02010;density lipoprotein receptor&#x02010;related protein</span>. <span class="ref-journal">J Cell Biol</span>. 1995;<span class="ref-vol">129</span>:1533&#x02010;1541. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2291175/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7790352" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biol&amp;title=Pseudomonas+exotoxin&#x02010;mediated+selection+yields+cells+with+altered+expression+of+low&#x02010;density+lipoprotein+receptor&#x02010;related+protein&amp;volume=129&amp;publication_year=1995&amp;pages=1533-1541&amp;pmid=7790352&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0025">25. <span class="mixed-citation" id="fba21236-cit-0025">Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS. <span class="ref-title">39&#x02010;kDa protein modulates binding of ligands to low density lipoprotein receptor&#x02010;related protein/&#x003b1;2&#x02010;macroglobulin receptor</span>. <span class="ref-journal">J Biol Chem</span>. 1991;<span class="ref-vol">266</span>:21232&#x02010;21238. [<a href="https://pubmed.ncbi.nlm.nih.gov/1718973" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=39&#x02010;kDa+protein+modulates+binding+of+ligands+to+low+density+lipoprotein+receptor&#x02010;related+protein/&#x003b1;2&#x02010;macroglobulin+receptor&amp;volume=266&amp;publication_year=1991&amp;pages=21232-21238&amp;pmid=1718973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0026">26. <span class="mixed-citation" id="fba21236-cit-0026">Cohen P, Klumpp S, Schelling DL. <span class="ref-title">An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues</span>. <span class="ref-journal">FEBS Lett</span>. 1989;<span class="ref-vol">250</span>:596&#x02010;600. [<a href="https://pubmed.ncbi.nlm.nih.gov/2546812" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FEBS+Lett&amp;title=An+improved+procedure+for+identifying+and+quantitating+protein+phosphatases+in+mammalian+tissues&amp;volume=250&amp;publication_year=1989&amp;pages=596-600&amp;pmid=2546812&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0027">27. <span class="mixed-citation" id="fba21236-cit-0027">Takai A, Eto M, Hirano K, Takeya K, Wakimoto T, Watanabe M. <span class="ref-title">Protein phosphatases 1 and 2A and their naturally occurring inhibitors: current topics in smooth muscle physiology and chemical biology</span>. <span class="ref-journal">J Physiol Sci</span>. 2018;<span class="ref-vol">68</span>:1&#x02010;17. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5754374/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28681362" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Physiol+Sci&amp;title=Protein+phosphatases+1+and+2A+and+their+naturally+occurring+inhibitors:+current+topics+in+smooth+muscle+physiology+and+chemical+biology&amp;volume=68&amp;publication_year=2018&amp;pages=1-17&amp;pmid=28681362&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0028">28. <span class="mixed-citation" id="fba21236-cit-0028">Gruppuso PA, Mikumo R, Brautigan DL. <span class="ref-title">Braun L Growth arrest induced by transforming growth factor &#x003b2;1 is accompanied by protein phosphatase activation in human keratinocytes</span>. <span class="ref-journal">J Biol Chem</span>. 1991;<span class="ref-vol">266</span>:3444&#x02010;3448. [<a href="https://pubmed.ncbi.nlm.nih.gov/1847373" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Braun+L+Growth+arrest+induced+by+transforming+growth+factor+&#x003b2;1+is+accompanied+by+protein+phosphatase+activation+in+human+keratinocytes&amp;volume=266&amp;publication_year=1991&amp;pages=3444-3448&amp;pmid=1847373&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0029">29. <span class="mixed-citation" id="fba21236-cit-0029">Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagu&#x000e9; J. <span class="ref-title">Growth inhibition by TGF&#x02010;&#x003b2; linked to suppression of retinoblastoma protein phosphorylation</span>. <span class="ref-journal">Cell</span>. 1990;<span class="ref-vol">62</span>:175&#x02010;185. [<a href="https://pubmed.ncbi.nlm.nih.gov/2163767" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Growth+inhibition+by+TGF&#x02010;&#x003b2;+linked+to+suppression+of+retinoblastoma+protein+phosphorylation&amp;volume=62&amp;publication_year=1990&amp;pages=175-185&amp;pmid=2163767&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0030">30. <span class="mixed-citation" id="fba21236-cit-0030">Chao R, Khan W, Hannun YA. <span class="ref-title">Retinoblastoma protein dephosphorylation induced by D&#x02010;erythro&#x02010;sphingosine</span>. <span class="ref-journal">J Biol Chem</span>. 1992;<span class="ref-vol">267</span>:23459&#x02010;23462. [<a href="https://pubmed.ncbi.nlm.nih.gov/1385423" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Retinoblastoma+protein+dephosphorylation+induced+by+D&#x02010;erythro&#x02010;sphingosine&amp;volume=267&amp;publication_year=1992&amp;pages=23459-23462&amp;pmid=1385423&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0031">31. <span class="mixed-citation" id="fba21236-cit-0031">Egger JV, Lane MV, Antonucci LA, Dedi B, Krucher NA. <span class="ref-title">Dephosphorylation of the Retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb</span>. <span class="ref-journal">Cancer Biol Ther</span>. 2016;<span class="ref-vol">17</span>:1197&#x02010;1205. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5137485/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27645778" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Biol+Ther&amp;title=Dephosphorylation+of+the+Retinoblastoma+protein+(Rb)+inhibits+cancer+cell+EMT+via+Zeb&amp;volume=17&amp;publication_year=2016&amp;pages=1197-1205&amp;pmid=27645778&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0032">32. <span class="mixed-citation" id="fba21236-cit-0032">Mittnacht S, Weinberg RA. <span class="ref-title">G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment</span>. <span class="ref-journal">Cell</span>. 1991;<span class="ref-vol">65</span>:381&#x02010;393. [<a href="https://pubmed.ncbi.nlm.nih.gov/2018973" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=G1/S+phosphorylation+of+the+retinoblastoma+protein+is+associated+with+an+altered+affinity+for+the+nuclear+compartment&amp;volume=65&amp;publication_year=1991&amp;pages=381-393&amp;pmid=2018973&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0033">33. <span class="mixed-citation" id="fba21236-cit-0033">Hertz EPT, Kruse T, Davey NE, et al. <span class="ref-title">A conserved motif provides binding specificity to the PP2A&#x02010;B56 phosphatase</span>. <span class="ref-journal">Mol Cell</span>. 2016;<span class="ref-vol">63</span>:686&#x02010;695. [<a href="https://pubmed.ncbi.nlm.nih.gov/27453045" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell&amp;title=A+conserved+motif+provides+binding+specificity+to+the+PP2A&#x02010;B56+phosphatase&amp;volume=63&amp;publication_year=2016&amp;pages=686-695&amp;pmid=27453045&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0034">34. <span class="mixed-citation" id="fba21236-cit-0034">Garcia A, Cayla X, Caudron B, Deveaud E, Roncal F, Rebollo A. <span class="ref-title">New insights in protein phosphorylation: a signature for protein phosphatase 1 interacting proteins</span>. <span class="ref-journal">C R Biol</span>. 2004;<span class="ref-vol">327</span>:93&#x02010;97. [<a href="https://pubmed.ncbi.nlm.nih.gov/15060979" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=C+R+Biol&amp;title=New+insights+in+protein+phosphorylation:+a+signature+for+protein+phosphatase+1+interacting+proteins&amp;volume=327&amp;publication_year=2004&amp;pages=93-97&amp;pmid=15060979&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0035">35. <span class="mixed-citation" id="fba21236-cit-0035">Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R. <span class="ref-title">Insulin&#x02010;like growth factor 1 receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2</span>. <span class="ref-journal">Mol Endocrinol</span>. 2003;<span class="ref-vol">17</span>:472&#x02010;486. [<a href="https://pubmed.ncbi.nlm.nih.gov/12554758" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Endocrinol&amp;title=Insulin&#x02010;like+growth+factor+1+receptor+signaling+and+nuclear+translocation+of+insulin+receptor+substrates+1+and+2&amp;volume=17&amp;publication_year=2003&amp;pages=472-486&amp;pmid=12554758&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0036">36. <span class="mixed-citation" id="fba21236-cit-0036">Chen X, Ferry RJ Jr. <span class="ref-title">Novel actions of IGFBP&#x02010;3 on intracellular signaling pathways of insulin&#x02010;secreting cells</span>. <span class="ref-journal">Growth Horm IGF Res</span>. 2006;<span class="ref-vol">16</span>:41&#x02010;48. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3092594/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16275148" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Growth+Horm+IGF+Res&amp;title=Novel+actions+of+IGFBP&#x02010;3+on+intracellular+signaling+pathways+of+insulin&#x02010;secreting+cells&amp;volume=16&amp;publication_year=2006&amp;pages=41-48&amp;pmid=16275148&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0037">37. <span class="mixed-citation" id="fba21236-cit-0037">Itoh S, Thorikay M, Kowanetz M, et al. <span class="ref-title">Elucidation of Smad requirement in transforming growth factor&#x02010;&#x003b2; type I receptor&#x02010;induced responses</span>. <span class="ref-journal">J Biol Chem</span>. 2003;<span class="ref-vol">278</span>:3751&#x02010;3761. [<a href="https://pubmed.ncbi.nlm.nih.gov/12446693" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Elucidation+of+Smad+requirement+in+transforming+growth+factor&#x02010;&#x003b2;+type+I+receptor&#x02010;induced+responses&amp;volume=278&amp;publication_year=2003&amp;pages=3751-3761&amp;pmid=12446693&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0038">38. <span class="mixed-citation" id="fba21236-cit-0038">Sorrentino A, Thakur N, Grimsby S, et al. <span class="ref-title">The type I TGF&#x02010;&#x003b2; receptor engages TRAF6 to activate TAK1 in a receptor kinase&#x02010;independent manner</span>. <span class="ref-journal">Nat Cell Biol</span>. 2008;<span class="ref-vol">10</span>:1199&#x02010;1207. [<a href="https://pubmed.ncbi.nlm.nih.gov/18758450" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Cell+Biol&amp;title=The+type+I+TGF&#x02010;&#x003b2;+receptor+engages+TRAF6+to+activate+TAK1+in+a+receptor+kinase&#x02010;independent+manner&amp;volume=10&amp;publication_year=2008&amp;pages=1199-1207&amp;pmid=18758450&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0039">39. <span class="mixed-citation" id="fba21236-cit-0039">Hamidi A, Song J, Thakur N, et al. <span class="ref-title">TGF&#x02010;&#x003b2; promotes PI3K&#x02010;AKT signaling and prostate cancer cell migration through the TRAF6&#x02010;mediated ubiquitylation of p85&#x003b1;</span>. <span class="ref-journal">Sci Signal</span>. 2017:<span class="ref-vol">10</span>;eaal4186. [<a href="https://pubmed.ncbi.nlm.nih.gov/28676490" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci+Signal&amp;title=TGF&#x02010;&#x003b2;+promotes+PI3K&#x02010;AKT+signaling+and+prostate+cancer+cell+migration+through+the+TRAF6&#x02010;mediated+ubiquitylation+of+p85&#x003b1;&amp;volume=10&amp;publication_year=2017&amp;pages=eaal4186&amp;pmid=28676490&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0040">40. <span class="mixed-citation" id="fba21236-cit-0040">Fleming YM, Ferguson GJ, Spender LC, et al. <span class="ref-title">TGF&#x02010;&#x003b2;&#x02010;mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation</span>. <span class="ref-journal">Oncogene</span>. 2009;<span class="ref-vol">28</span>:983&#x02010;993. [<a href="https://pubmed.ncbi.nlm.nih.gov/19079344" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=TGF&#x02010;&#x003b2;&#x02010;mediated+activation+of+RhoA+signalling+is+required+for+efficient+(V12)HaRas+and+(V600E)BRAF+transformation&amp;volume=28&amp;publication_year=2009&amp;pages=983-993&amp;pmid=19079344&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0041">41. <span class="mixed-citation" id="fba21236-cit-0041">Griswold&#x02010;Prenner I, Kamibayashi C, Maruoka EM, Mumby MC, Derynck R. <span class="ref-title">Physical and functional interactions between type I transforming growth factor &#x003b2; receptors and B&#x003b1;, a WD&#x02010;40 repeat subunit of phosphatase 2A</span>. <span class="ref-journal">Mol Cell Biol</span>. 1998;<span class="ref-vol">18</span>:6595&#x02010;6604. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC109244/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9774674" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Physical+and+functional+interactions+between+type+I+transforming+growth+factor+&#x003b2;+receptors+and+B&#x003b1;,+a+WD&#x02010;40+repeat+subunit+of+phosphatase+2A&amp;volume=18&amp;publication_year=1998&amp;pages=6595-6604&amp;pmid=9774674&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0042">42. <span class="mixed-citation" id="fba21236-cit-0042">Yu N, Kozlowski JM, Park II, et al. <span class="ref-title">Overexpression of transforming growth factor &#x003b2;1 in malignant prostate cells is partly caused by a runaway of TGF&#x02010;&#x003b2;1 auto&#x02010;induction mediated through a defective recruitment of protein phosphatase 2A by TGF&#x02010;&#x003b2; type I receptor</span>. <span class="ref-journal">Urol</span>. 2010;<span class="ref-vol">76</span>(<span class="ref-iss">1519</span>):e8&#x02010;13. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2997920/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21030067" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Urol&amp;title=Overexpression+of+transforming+growth+factor+&#x003b2;1+in+malignant+prostate+cells+is+partly+caused+by+a+runaway+of+TGF&#x02010;&#x003b2;1+auto&#x02010;induction+mediated+through+a+defective+recruitment+of+protein+phosphatase+2A+by+TGF&#x02010;&#x003b2;+type+I+receptor&amp;volume=76&amp;issue=1519&amp;publication_year=2010&amp;pages=e8-13&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0043">43. <span class="mixed-citation" id="fba21236-cit-0043">Zhao L, He LR, Zhang R, et al. <span class="ref-title">Low expression of IGFBP&#x02010;3 predicts poor prognosis in patients with esophageal squamous cell carcinoma</span>. <span class="ref-journal">Med Oncol</span>. 2012;<span class="ref-vol">29</span>:2669&#x02010;2676. [<a href="https://pubmed.ncbi.nlm.nih.gov/22167391" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Med+Oncol&amp;title=Low+expression+of+IGFBP&#x02010;3+predicts+poor+prognosis+in+patients+with+esophageal+squamous+cell+carcinoma&amp;volume=29&amp;publication_year=2012&amp;pages=2669-2676&amp;pmid=22167391&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0044">44. <span class="mixed-citation" id="fba21236-cit-0044">Yan J, Yang X, Li L, et al. <span class="ref-title">Low expression levels of insulin&#x02010;like growth factor binding protein&#x02010;3 are correlated with poor prognosis for patients with hepatocellular carcinoma</span>. <span class="ref-journal">Oncol Lett</span>. 2017;<span class="ref-vol">13</span>:3395&#x02010;3402. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5431398/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28521445" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncol+Lett&amp;title=Low+expression+levels+of+insulin&#x02010;like+growth+factor+binding+protein&#x02010;3+are+correlated+with+poor+prognosis+for+patients+with+hepatocellular+carcinoma&amp;volume=13&amp;publication_year=2017&amp;pages=3395-3402&amp;pmid=28521445&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0045">45. <span class="mixed-citation" id="fba21236-cit-0045">Torng PL, Lin CW, Chan MW, Yang HW, Huang SC, Lin CT. <span class="ref-title">Promoter methylation of IGFBP&#x02010;3 and p53 expression in ovarian endometrioid carcinoma</span>. <span class="ref-journal">Mol Cancer</span>. 2009;<span class="ref-vol">8</span>:120. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2799391/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20003326" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer&amp;title=Promoter+methylation+of+IGFBP&#x02010;3+and+p53+expression+in+ovarian+endometrioid+carcinoma&amp;volume=8&amp;publication_year=2009&amp;pages=120&amp;pmid=20003326&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0046">46. <span class="mixed-citation" id="fba21236-cit-0046">Lambrecht C, Libbrecht L, Sagaert X, et al. <span class="ref-title">Loss of protein phosphatase 2A regulatory subunit B56&#x003b4; promotes spontaneous tumorigenesis <em>in vivo</em>
</span>. <span class="ref-journal">Oncogene</span>. 2018;<span class="ref-vol">37</span>:544&#x02010;552. [<a href="https://pubmed.ncbi.nlm.nih.gov/28967903" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Loss+of+protein+phosphatase+2A+regulatory+subunit+B56&#x003b4;+promotes+spontaneous+tumorigenesis+in+vivo&#10;&amp;volume=37&amp;publication_year=2018&amp;pages=544-552&amp;pmid=28967903&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0047">47. <span class="mixed-citation" id="fba21236-cit-0047">Herz J, Clouthier DE, Hammer RE. <span class="ref-title">LDL receptor&#x02010;related protein internalizes and degrades uPA&#x02010;PAI&#x02010;1 complexes and is essential for embryo implantation</span>. <span class="ref-journal">Cell</span>. 1992;<span class="ref-vol">71</span>:411&#x02010;421. [<a href="https://pubmed.ncbi.nlm.nih.gov/1423604" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=LDL+receptor&#x02010;related+protein+internalizes+and+degrades+uPA&#x02010;PAI&#x02010;1+complexes+and+is+essential+for+embryo+implantation&amp;volume=71&amp;publication_year=1992&amp;pages=411-421&amp;pmid=1423604&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0048">48. <span class="mixed-citation" id="fba21236-cit-0048">Lin SC, Skapek SX, Lee EY. <span class="ref-title">Genes in the RB pathway and their knockout in mice</span>. <span class="ref-journal">Semin Cancer Biol</span>. 1996;<span class="ref-vol">7</span>:279&#x02010;289. [<a href="https://pubmed.ncbi.nlm.nih.gov/9110405" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Cancer+Biol&amp;title=Genes+in+the+RB+pathway+and+their+knockout+in+mice&amp;volume=7&amp;publication_year=1996&amp;pages=279-289&amp;pmid=9110405&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0049">49. <span class="mixed-citation" id="fba21236-cit-0049">Ingermann AR, Yang YF, Han J, et al. <span class="ref-title">Identification of a novel cell death receptor mediating IGFBP&#x02010;3&#x02010;induced anti&#x02010;tumor effects in breast and prostate cancer</span>. <span class="ref-journal">J Biol Chem</span>. 2010;<span class="ref-vol">285</span>:30233&#x02010;30246. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2943278/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20353938" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Identification+of+a+novel+cell+death+receptor+mediating+IGFBP&#x02010;3&#x02010;induced+anti&#x02010;tumor+effects+in+breast+and+prostate+cancer&amp;volume=285&amp;publication_year=2010&amp;pages=30233-30246&amp;pmid=20353938&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0050">50. <span class="mixed-citation" id="fba21236-cit-0050">Cai Q, Dozmorov M, Oh Y. <span class="ref-title">IGFBP&#x02010;3/IGFBP&#x02010;3 receptor system as an anti&#x02010;tumor and anti&#x02010;metastatic signaling in cancer</span>. <span class="ref-journal">Cells</span>. 2020;<span class="ref-vol">9</span>:1261. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7290346/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32443727" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=IGFBP&#x02010;3/IGFBP&#x02010;3+receptor+system+as+an+anti&#x02010;tumor+and+anti&#x02010;metastatic+signaling+in+cancer&amp;volume=9&amp;publication_year=2020&amp;pages=1261&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0051">51. <span class="mixed-citation" id="fba21236-cit-0051">Joyce S, Nour AM. <span class="ref-title">Blocking transmembrane 219 protein signaling inhibits autophagy and restores normal cell death</span>. <span class="ref-journal">PLoS One</span>. 2019;<span class="ref-vol">14</span>:e0218091. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6586287/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31220095" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Blocking+transmembrane+219+protein+signaling+inhibits+autophagy+and+restores+normal+cell+death&amp;volume=14&amp;publication_year=2019&amp;pages=e0218091&amp;pmid=31220095&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0052">52. <span class="mixed-citation" id="fba21236-cit-0052">Howe PH, Cunningham MR, Leof EB. <span class="ref-title">Distinct pathways regulate transforming growth factor &#x003b2;1&#x02010;stimulated proto&#x02010;oncogene and extracellular matrix gene expression</span>. <span class="ref-journal">J Cell Physiol</span>. 1990;<span class="ref-vol">42</span>:39&#x02010;45. [<a href="https://pubmed.ncbi.nlm.nih.gov/2153688" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Physiol&amp;title=Distinct+pathways+regulate+transforming+growth+factor+&#x003b2;1&#x02010;stimulated+proto&#x02010;oncogene+and+extracellular+matrix+gene+expression&amp;volume=42&amp;publication_year=1990&amp;pages=39-45&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0053">53. <span class="mixed-citation" id="fba21236-cit-0053">Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R. <span class="ref-title">A WD&#x02010;domain protein that is associated with and phosphorylated by the type II TGF&#x02010;&#x003b2; receptor</span>. <span class="ref-journal">Nature</span>. 1995;<span class="ref-vol">377</span>:548&#x02010;552. [<a href="https://pubmed.ncbi.nlm.nih.gov/7566156" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+WD&#x02010;domain+protein+that+is+associated+with+and+phosphorylated+by+the+type+II+TGF&#x02010;&#x003b2;+receptor&amp;volume=377&amp;publication_year=1995&amp;pages=548-552&amp;pmid=7566156&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0054">54. <span class="mixed-citation" id="fba21236-cit-0054">Macias&#x02010;Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. <span class="ref-title">MADR2 is a substrate of the TGF&#x02010;&#x003b2; receptor and its phosphorylation is required for nuclear accumulation and signaling</span>. <span class="ref-journal">Cell</span>. 1996;<span class="ref-vol">87</span>:1215&#x02010;1224. [<a href="https://pubmed.ncbi.nlm.nih.gov/8980228" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=MADR2+is+a+substrate+of+the+TGF&#x02010;&#x003b2;+receptor+and+its+phosphorylation+is+required+for+nuclear+accumulation+and+signaling&amp;volume=87&amp;publication_year=1996&amp;pages=1215-1224&amp;pmid=8980228&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0055">55. <span class="mixed-citation" id="fba21236-cit-0055">Hall FL, Benya PD, Padilla SR, et al. <span class="ref-title">Transforming growth factor&#x02010;&#x003b2; type&#x02010;ll receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies</span>. <span class="ref-journal">Biochem J</span>. 1996;<span class="ref-vol">316</span>:303&#x02010;310. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1217339/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8645222" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+J&amp;title=Transforming+growth+factor&#x02010;&#x003b2;+type&#x02010;ll+receptor+signalling:+intrinsic/associated+casein+kinase+activity,+receptor+interactions+and+functional+effects+of+blocking+antibodies&amp;volume=316&amp;publication_year=1996&amp;pages=303-310&amp;pmid=8645222&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0056">56. <span class="mixed-citation" id="fba21236-cit-0056">Hocevar BA, Howe PH. <span class="ref-title">Mechanisms of TGF&#x02010;&#x003b2;&#x02010;induced cell cycle arrest</span>. <span class="ref-journal">Miner Electrolyte Metab</span>. 1998;<span class="ref-vol">24</span>:131&#x02010;135. [<a href="https://pubmed.ncbi.nlm.nih.gov/9525695" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Miner+Electrolyte+Metab&amp;title=Mechanisms+of+TGF&#x02010;&#x003b2;&#x02010;induced+cell+cycle+arrest&amp;volume=24&amp;publication_year=1998&amp;pages=131-135&amp;pmid=9525695&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0057">57. <span class="mixed-citation" id="fba21236-cit-0057">Heldin NE, Bergstrom D, Hermansson A, et al. <span class="ref-title">Lack of responsiveness to TGF&#x02010;&#x003b2; in a thyroid carcinoma cell line with functional type I and type II TGF&#x02010;&#x003b2; receptors and Smad proteins, suggests a novel mechanism for TGF&#x02010;&#x003b2; insensitivity in carcinoma cells</span>. <span class="ref-journal">Mol Cell Endocrinol</span>. 1999;<span class="ref-vol">153</span>:79&#x02010;90. [<a href="https://pubmed.ncbi.nlm.nih.gov/10459856" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Endocrinol&amp;title=Lack+of+responsiveness+to+TGF&#x02010;&#x003b2;+in+a+thyroid+carcinoma+cell+line+with+functional+type+I+and+type+II+TGF&#x02010;&#x003b2;+receptors+and+Smad+proteins,+suggests+a+novel+mechanism+for+TGF&#x02010;&#x003b2;+insensitivity+in+carcinoma+cells&amp;volume=153&amp;publication_year=1999&amp;pages=79-90&amp;pmid=10459856&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0058">58. <span class="mixed-citation" id="fba21236-cit-0058">Fink SP, Swinler SE, Lutterbaugh JD, et al. <span class="ref-title">Transforming growth factor&#x02010;&#x003b2;&#x02010;induced growth inhibition in a Smad4 mutant colon adenoma cell line</span>. <span class="ref-journal">Cancer Res</span>. 2001;<span class="ref-vol">61</span>:256&#x02010;260. [<a href="https://pubmed.ncbi.nlm.nih.gov/11196171" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Transforming+growth+factor&#x02010;&#x003b2;&#x02010;induced+growth+inhibition+in+a+Smad4+mutant+colon+adenoma+cell+line&amp;volume=61&amp;publication_year=2001&amp;pages=256-260&amp;pmid=11196171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0059">59. <span class="mixed-citation" id="fba21236-cit-0059">Petritsch C, Beug H, Balmain A, Oft M. <span class="ref-title">TGF&#x02010;&#x003b2; inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest</span>. <span class="ref-journal">Genes Dev</span>. 2000;<span class="ref-vol">14</span>:3093&#x02010;3101. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC317138/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11124802" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+Dev&amp;title=TGF&#x02010;&#x003b2;+inhibits+p70+S6+kinase+via+protein+phosphatase+2A+to+induce+G(1)+arrest&amp;volume=14&amp;publication_year=2000&amp;pages=3093-3101&amp;pmid=11124802&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0060">60. <span class="mixed-citation" id="fba21236-cit-0060">Moulder KM. <span class="ref-title">Role of Ras and Mapks in TGF&#x02010;&#x003b2; signaling</span>. <span class="ref-journal">Cytokine Growth Factor Rev</span>. 2000;<span class="ref-vol">11</span>:23&#x02010;35. [<a href="https://pubmed.ncbi.nlm.nih.gov/10708950" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine+Growth+Factor+Rev&amp;title=Role+of+Ras+and+Mapks+in+TGF&#x02010;&#x003b2;+signaling&amp;volume=11&amp;publication_year=2000&amp;pages=23-35&amp;pmid=10708950&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0061">61. <span class="mixed-citation" id="fba21236-cit-0061">Stenvers KL, Tursky ML, Harder KW, et al. <span class="ref-title">Heart and liver defects and reduced transforming growth factor &#x003b2;2 sensitivity in transforming growth factor &#x003b2; type III receptor&#x02010;deficient embryos</span>. <span class="ref-journal">Mol Cell Biol</span>. 2003;<span class="ref-vol">23</span>:4371&#x02010;4385. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC156130/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12773577" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=Heart+and+liver+defects+and+reduced+transforming+growth+factor+&#x003b2;2+sensitivity+in+transforming+growth+factor+&#x003b2;+type+III+receptor&#x02010;deficient+embryos&amp;volume=23&amp;publication_year=2003&amp;pages=4371-4385&amp;pmid=12773577&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0062">62. <span class="mixed-citation" id="fba21236-cit-0062">Benes P, Jurajda M, Zaloud&#x000ed;k J, Izakovicov&#x000e1;&#x02010;Holl&#x000e1; L, V&#x000e1;cha J. <span class="ref-title">C766T low&#x02010;density lipoprotein receptor&#x02010;related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer</span>. <span class="ref-journal">Breast Cancer Res</span>. 2003;<span class="ref-vol">5</span>:R77&#x02010;81. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC165006/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12793904" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Breast+Cancer+Res&amp;title=C766T+low&#x02010;density+lipoprotein+receptor&#x02010;related+protein+1+(LRP1)+gene+polymorphism+and+susceptibility+to+breast+cancer&amp;volume=5&amp;publication_year=2003&amp;pages=R77-81&amp;pmid=12793904&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0063">63. <span class="mixed-citation" id="fba21236-cit-0063">Westermarck J, Li SP, Kallunki T, Han J, K&#x000e4;h&#x000e4;ri VM. <span class="ref-title">p38 mitogen&#x02010;activated protein kinase&#x02010;dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP&#x02010;1) gene expression</span>. <span class="ref-journal">Mol Cell Biol</span>. 2001;<span class="ref-vol">21</span>:2373&#x02010;2383. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC86870/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11259586" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cell+Biol&amp;title=p38+mitogen&#x02010;activated+protein+kinase&#x02010;dependent+activation+of+protein+phosphatases+1+and+2A+inhibits+MEK1+and+MEK2+activity+and+collagenase+1+(MMP&#x02010;1)+gene+expression&amp;volume=21&amp;publication_year=2001&amp;pages=2373-2383&amp;pmid=11259586&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0064">64. <span class="mixed-citation" id="fba21236-cit-0064">Grallert A, Boke E, Hagting A, et al. <span class="ref-title">A PP1&#x02010;PP2A phosphatase relay controls mitotic progression</span>. <span class="ref-journal">Nature</span>. 2015;<span class="ref-vol">517</span>:94&#x02010;98. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4338534/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25487150" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A+PP1&#x02010;PP2A+phosphatase+relay+controls+mitotic+progression&amp;volume=517&amp;publication_year=2015&amp;pages=94-98&amp;pmid=25487150&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0065">65. <span class="mixed-citation" id="fba21236-cit-0065">Razani B, Zhang XL, Bitzer M, von Gersdorff G, Bottinger EP, Lisanti MP. <span class="ref-title">Caveolin&#x02010;1 regulates transforming growth factor (TGF)&#x02010;&#x003b2;/SMAD signaling through an interaction with the TGF&#x02010;&#x003b2; type I receptor</span>. <span class="ref-journal">J Biol Chem</span>. 2001;<span class="ref-vol">276</span>:6727&#x02010;6738. [<a href="https://pubmed.ncbi.nlm.nih.gov/11102446" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Caveolin&#x02010;1+regulates+transforming+growth+factor+(TGF)&#x02010;&#x003b2;/SMAD+signaling+through+an+interaction+with+the+TGF&#x02010;&#x003b2;+type+I+receptor&amp;volume=276&amp;publication_year=2001&amp;pages=6727-6738&amp;pmid=11102446&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0066">66. <span class="mixed-citation" id="fba21236-cit-0066">Zuo W, Chen YG. <span class="ref-title">Specific activation of mitogen&#x02010;activated protein kinase by transforming growth factor&#x02010;&#x003b2; receptors in lipid rafts is required for epithelial cell plasticity</span>. <span class="ref-journal">Mol Biol Cell</span>. 2009;<span class="ref-vol">20</span>:1020&#x02010;1029. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2633387/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19056678" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=Specific+activation+of+mitogen&#x02010;activated+protein+kinase+by+transforming+growth+factor&#x02010;&#x003b2;+receptors+in+lipid+rafts+is+required+for+epithelial+cell+plasticity&amp;volume=20&amp;publication_year=2009&amp;pages=1020-1029&amp;pmid=19056678&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0067">67. <span class="mixed-citation" id="fba21236-cit-0067">McClinch K, Avelar RA, Callejas D, et al. <span class="ref-title">Small&#x02010;molecule activators of protein phosphatase 2A for the treatment of castration&#x02010;resistant prostate cancer</span>. <span class="ref-journal">Cancer Res</span>. 2018;<span class="ref-vol">78</span>:2065&#x02010;2080. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5899650/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29358171" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Small&#x02010;molecule+activators+of+protein+phosphatase+2A+for+the+treatment+of+castration&#x02010;resistant+prostate+cancer&amp;volume=78&amp;publication_year=2018&amp;pages=2065-2080&amp;pmid=29358171&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0068">68. <span class="mixed-citation" id="fba21236-cit-0068">Hannigan A, Smith P, Kalna G, et al. <span class="ref-title">Epigenetic downregulation of human disabled homolog 2 switches TGF&#x02010;&#x003b2; from a tumor suppressor to a tumor promoter</span>. <span class="ref-journal">J Clin Invest</span>. 2010;<span class="ref-vol">120</span>:2842&#x02010;2857. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2912175/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20592473" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Epigenetic+downregulation+of+human+disabled+homolog+2+switches+TGF&#x02010;&#x003b2;+from+a+tumor+suppressor+to+a+tumor+promoter&amp;volume=120&amp;publication_year=2010&amp;pages=2842-2857&amp;pmid=20592473&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0069">69. <span class="mixed-citation" id="fba21236-cit-0069">Huang JS. Invited Faculty Speaker
. Mechanism of switching TG&#x02010;&#x003b2; from a tumor suppressor to a tumor promoter: implications for the prevention and treatment of human cancer. <em>The 8th International Congress on Cancer metastasis</em>, San Francisco, CA, USA; 2019. Abstract:AB 22. <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=Huang+JS+.++Invited+Faculty+Speaker+&#10;.+Mechanism+of+switching+TG&#x02010;&#x003b2;+from+a+tumor+suppressor+to+a+tumor+promoter:+implications+for+the+prevention+and+treatment+of+human+cancer.++The+8th+International+Congress+on+Cancer+metastasis+,++San+Francisco,+CA,+USA+;++2019+.+Abstract:AB+22.+" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0070">70. <span class="mixed-citation" id="fba21236-cit-0070">Pampusch MS, Kamanga&#x02010;Sollo E, Hathaway MR, White ME, Dayton WR. <span class="ref-title">Low&#x02010;density lipoprotein&#x02010;related receptor protein 1 (LRP&#x02010;1) is not required for insulin&#x02010;like growth factor binding protein 3 (IGFBP&#x02010;3) to suppress L6 myogenic cell proliferation</span>. <span class="ref-journal">Domest Anim Endocrinol</span>. 2011;<span class="ref-vol">40</span>:197&#x02010;204. [<a href="https://pubmed.ncbi.nlm.nih.gov/21353438" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Domest+Anim+Endocrinol&amp;title=Low&#x02010;density+lipoprotein&#x02010;related+receptor+protein+1+(LRP&#x02010;1)+is+not+required+for+insulin&#x02010;like+growth+factor+binding+protein+3+(IGFBP&#x02010;3)+to+suppress+L6+myogenic+cell+proliferation&amp;volume=40&amp;publication_year=2011&amp;pages=197-204&amp;pmid=21353438&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0071">71. <span class="mixed-citation" id="fba21236-cit-0071">Lee Y&#x02010;R, Chen M, Lee JD, et al. <span class="ref-title">Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC&#x02010;WWP1 inhibitory pathway</span>. <span class="ref-journal">Science</span>. 2019;<span class="ref-vol">364</span>(<span class="ref-iss">6441</span>):eaau0159. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7081834/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31097636" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Reactivation+of+PTEN+tumor+suppressor+for+cancer+treatment+through+inhibition+of+a+MYC&#x02010;WWP1+inhibitory+pathway&amp;volume=364&amp;issue=6441&amp;publication_year=2019&amp;pages=eaau0159&amp;pmid=31097636&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0072">72. <span class="mixed-citation" id="fba21236-cit-0072">Huang SS, Liu I&#x02010;H, Chen C&#x02010;L, Chang JM, Johnson FE, Huang JS. <span class="ref-title">7&#x02010;Dehydrocholesterol (7&#x02010;DHC), but not cholesterol, causes suppression of canonical TGF&#x02010;&#x003b2; signaling and is likely involved in the development of atherosclerotic cardiovascular disease (ASCVD)</span>. <span class="ref-journal">J Cell Biochem</span>. 2017;<span class="ref-vol">118</span>:1387&#x02010;1400. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6123222/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27862220" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem&amp;title=7&#x02010;Dehydrocholesterol+(7&#x02010;DHC),+but+not+cholesterol,+causes+suppression+of+canonical+TGF&#x02010;&#x003b2;+signaling+and+is+likely+involved+in+the+development+of+atherosclerotic+cardiovascular+disease+(ASCVD)&amp;volume=118&amp;publication_year=2017&amp;pages=1387-1400&amp;pmid=27862220&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0073">73. <span class="mixed-citation" id="fba21236-cit-0073">Huang JS, Huang FW, Johnson FE, Huang SS. Molecular basis of diets, exercise and lifestyle interventions in atherosclerotic cardiovascular disease. In: Lewis BS, Borer JS, Halon DA, eds. <span class="ref-journal">The Proceedings of the 11th International Congress on Coronary Artery Disease</span>, 2015:49&#x02010;52. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=The+Proceedings+of+the+11th+International+Congress+on+Coronary+Artery+Disease&amp;publication_year=2015&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0074">74. <span class="mixed-citation" id="fba21236-cit-0074">Chen C&#x02010;L, Hou W&#x02010;H, Liu I&#x02010;H, Huang SS, Huang JS. <span class="ref-title">Inhibitors of clarthrin&#x02010;dependent endocytosis inhibitors enhance TGF&#x02010;&#x003b2; signaling and responses</span>. <span class="ref-journal">J Cell Sci</span>. 2009;<span class="ref-vol">122</span>:1863&#x02010;1871. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2684837/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19461075" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Sci&amp;title=Inhibitors+of+clarthrin&#x02010;dependent+endocytosis+inhibitors+enhance+TGF&#x02010;&#x003b2;+signaling+and+responses&amp;volume=122&amp;publication_year=2009&amp;pages=1863-1871&amp;pmid=19461075&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0075">75. <span class="mixed-citation" id="fba21236-cit-0075">Huang SS, Chen CL, Huang FW, Johnson FE, Huang JS. <span class="ref-title">Ethanol enhances TGF&#x02010;&#x003b2; Activity by recruiting TGF&#x02010;&#x003b2; receptors from intracellular vesicles/lipid rafts/caveolae to non&#x02010;lipid raft microdomains</span>. <span class="ref-journal">J Cell Biochem</span>. 2016;<span class="ref-vol">117</span>:860&#x02010;871. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6123223/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26419316" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem&amp;title=Ethanol+enhances+TGF&#x02010;&#x003b2;+Activity+by+recruiting+TGF&#x02010;&#x003b2;+receptors+from+intracellular+vesicles/lipid+rafts/caveolae+to+non&#x02010;lipid+raft+microdomains&amp;volume=117&amp;publication_year=2016&amp;pages=860-871&amp;pmid=26419316&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0076">76. <span class="mixed-citation" id="fba21236-cit-0076">Huang SS, Chen CL, Huang FW, Hou W&#x02010;H, Huang JS. <span class="ref-title">Dimethyl sulfoxide enhances TGF&#x02010;&#x003b2; activity by recruiting the type II TGF&#x02010;&#x003b2; receptor from intracellular vesicles/lipid rafts/caveolae to the plasma membrane</span>. <span class="ref-journal">J Cell Biochem</span>. 2016;<span class="ref-vol">117</span>:1568&#x02010;1579. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6123219/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26587792" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Cell+Biochem&amp;title=Dimethyl+sulfoxide+enhances+TGF&#x02010;&#x003b2;+activity+by+recruiting+the+type+II+TGF&#x02010;&#x003b2;+receptor+from+intracellular+vesicles/lipid+rafts/caveolae+to+the+plasma+membrane&amp;volume=117&amp;publication_year=2016&amp;pages=1568-1579&amp;pmid=26587792&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0077">77. <span class="mixed-citation" id="fba21236-cit-0077">Arranz S, Chiva&#x02010;Blanch G, Valderas&#x02010;Mart&#x000ed;nez P, Medina&#x02010;Rem&#x000f3;n A, Lamuela&#x02010;Ravent&#x000f3;s RM, Estruch R. <span class="ref-title">Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer</span>. <span class="ref-journal">Nutrients</span>. 2012;<span class="ref-vol">4</span>:759&#x02010;781. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3407993/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22852062" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nutrients&amp;title=Wine,+beer,+alcohol+and+polyphenols+on+cardiovascular+disease+and+cancer&amp;volume=4&amp;publication_year=2012&amp;pages=759-781&amp;pmid=22852062&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0078">78. <span class="mixed-citation" id="fba21236-cit-0078">Mahdy Ali K, Wonnerth A, Huber K, Wojta J. <span class="ref-title">Cardiovascular disease risk reduction by raising HDL cholesterol &#x02013; current therapies and future opportunities</span>. <span class="ref-journal">Br J Pharmacol</span>. 2012;<span class="ref-vol">167</span>:1177&#x02010;1194. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3504986/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22725625" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Pharmacol&amp;title=Cardiovascular+disease+risk+reduction+by+raising+HDL+cholesterol+&#x02013;+current+therapies+and+future+opportunities&amp;volume=167&amp;publication_year=2012&amp;pages=1177-1194&amp;pmid=22725625&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0079">79. <span class="mixed-citation" id="fba21236-cit-0079">Grainger DJ. <span class="ref-title">Transforming growth factor and atherosclerosis: so far, so good for the protective cytokine hypothesis</span>. <span class="ref-journal">Arterioscler Thromb Vasc Biol</span>. 2004;<span class="ref-vol">24</span>:399&#x02010;404. [<a href="https://pubmed.ncbi.nlm.nih.gov/14699019" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler+Thromb+Vasc+Biol&amp;title=Transforming+growth+factor+and+atherosclerosis:+so+far,+so+good+for+the+protective+cytokine+hypothesis&amp;volume=24&amp;publication_year=2004&amp;pages=399-404&amp;pmid=14699019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="fba21236-bib-0080">80. <span class="mixed-citation" id="fba21236-cit-0080">Wu L, Derynck R. <span class="ref-title">Essential role of TGF&#x02010;&#x003b2; signaling in glucose&#x02010;induced cell hypertrophy</span>. <span class="ref-journal">Dev Cell</span>. 2009;<span class="ref-vol">17</span>:35&#x02010;48. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2722039/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19619490" ref="reftype=pubmed&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dev+Cell&amp;title=Essential+role+of+TGF&#x02010;&#x003b2;+signaling+in+glucose&#x02010;induced+cell+hypertrophy&amp;volume=17&amp;publication_year=2009&amp;pages=35-48&amp;pmid=19619490&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8409558&amp;issue-id=389192&amp;journal-id=3792&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">FASEB BioAdvances</span> are provided here courtesy of <strong>Wiley</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8409558/pdf/FBA2-3-709.pdf" class="int-view">PDF (1.4M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8409558/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8409558/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8409558" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="PIGYYpvP2xOJu0Lw28iy4SDcgICHINMKXdr3MbSXjkazlrqn9pDwylfmB1KhTH5x">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F&amp;text=IGFBP%020103%20and%20TGF%02010%003B2%20inhibit%20growth%20in%20epithelial%20cells%20by%20stimulating%20type%20V%20TGF%02010%003B2%20..." alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8409558%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409558/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34485840/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34485840/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8409558/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8409558/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8409558/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
